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Abstract 
Non-typhoidal Salmonella epidemics have a huge impact on animal and human health. 
During the 1980’s a new epidemic strain emerged, S. Typhimurium DT104, first in the UK 
but later spreading through Europe and North America. This phage type displayed resistance 
to a panel of antibiotics and was isolated from cattle, pigs and poultry as well as from human 
clinical infections. By the 2000’s, infections by this strain were subsiding, while other 
epidemic strains of Salmonella were emerging.  
 
This study used Comparative Genomic Hybridisation (CGH) arrays to screen DT104 
strains from before, during and after the epidemic period, to interrogate the genetic changes 
that may have contributed to the strain epidemicity. Two novel techniques, optical mapping 
and the Biolog phenotypic microarray, were used to confirm or refute the CGH results. The 
study found that the major difference between pre-epidemic and epidemic strains was the 
acquisition of the antibiotic resistance carrying Salmonella Genomic Island 1 (SGI1). This 
region showed increased variation towards the latter period. In addition, genes involved in the 
theorised production of a ‘pertussis like’ toxin were found to be present in human epidemic 
strains, while they varied or were missing from strains of animal origin and human pre-
epidemic sensitive strains. Other differences were found in the presence of genes for allantoin 
and glyoxylate utilisation for strains that may represent an ancestral clone of DT104.  The 
CGH results revealed variation and this variation was confirmed by phenotypic assay and 
confirmatory techniques.  
 
Overall the picture of DT104 epidemicity is complex, but this study has identified 
areas of potential importance and has suggested avenues of research, that may lead to a 
deeper understanding of how epidemics develop.  
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1 Introduction 
This study considers some of the factors that underlie the emergence of epidemic Salmonella 
enterica strains, the mechanisms by which they become prevalent, the processes of their 
evolution and the implications of these processes on genetic characteristics and resultant 
phenotype with regard to developing potential management and control measures. The 
importance of discovering the reasons behind epidemics of Salmonella is underlined by the 
economic cost on both health services and to the farming industry. In 2007 the cost of human 
Salmonella infections was calculated at over $2.5 billion (ERS, 2008). 
Classic epidemiology tells us that in broad terms there are three major components to 
consider, namely the organism, the host with which it interacts and the environment through 
which the organism passes. No one study can realistically cover all these aspects and so the 
focus here is upon gaining an understanding of the organism selected for  study, Salmonella 
enterica  subs. enterica ser. Typhimurium definitive type (DT) 104 that emerged as a 
significant epidemic type during the 1980’s and throughout the 1990’s – 2000’s. 
This chapter will introduce the fundamentals of Salmonella that will impact on this 
study as well as outline the aims of the project. 
1.1 Overview of Salmonella 
Salmonella is an important zoonotic pathogen linked with serious animal and human disease. 
It is one of the most common causes of food-borne infections in man (Plym Forshell, 2006). 
Typhoidal salmonellosis or typhoid fever was estimated to have caused 22 million illnesses 
and over 200,000 deaths in the year 2000. Paratyphoid fever caused 5 million cases for the 
same time period (Crump, 2004). Non-typhoidal salmonellosis which includes that caused by 
S. Typhimurium also has a high burden with an estimated 1.4 million cases in the USA 
9 
 
annually with 15,000 hospitalisations and 400 deaths (Mead, 1999; Voetsch, 2004). There 
were also over 17,500 cases reported to laboratories in the UK in 1999 (WHO, 2003). 
The genus Salmonella is a member of the family Enterobacteriaceae and consists of a 
collection of closely related Gram-negative, rod shaped, non-spore forming bacterial species. 
Traditional methods of typing have relied on antigenic reaction to highly variable surface 
antigens expressed by the bacterium. These include the O-antigen of surface 
lipopolysaccharide (LPS) and the H-antigen of surface expressed flagella. Most Salmonella 
contain two flagellin genes which code for H1 and H2 variants of the H antigen, and 
serotyping has to include phase conversion to identify both types (Popoff, 2001).  
Studies into nucleotide sequence relationships have shown that, typically, Salmonella 
are 85–100% related (Crosa, 1973). In addition multilocus enzyme electrophoresis (MLEE) 
studies have shown that S. bongori has a higher level of difference, with only a 43% 
similarity to other Salmonella strains (Reeves, 1989). The MLEE technique compares the 
electrophoretic mobility of core enzymes, and has a lower resolution than molecular 
techniques such as MLST. These approaches have resulted in the separation of Salmonella 
into two species S. enterica and S. bongori. S. enterica is further sub-divided into six 
subspecies, enterica, salamae, arizonae, diarizonae, indica and houtenae. They are classified 
respectively into subspecies I, II, IIIa, IIIb, IV and VI. S. bongori was previously designated 
as subspecies V. The White-Kauffmann-Le Minor scheme divides the subspecies further into 
2541 serovars via their antigenic profile (Popoff, 2002). Over half of these are contained in S. 
enterica subspecies enterica, whereas the species S. bongori accounts for only 21 of the 
serovars (Popoff, 2001). MLEE has suggested an additional subspecies, VII, related to subsp. 
IV (Boyd et al., 2001) although this group is not distinguishable by unique biochemical 
properties. The phylogenetic relationship between the species and subspecies has been 
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resolved by analysing the nucleotide information from 4 houskeeping genes, gapA, phoP, 
mdh and recA (McQuiston, 2008). 
Other methods of typing have been developed to further differentiate within 
serotypes, of which one is bacteriophage or ‘phage’ typing. The first scheme used on an 
international scale took advantage of adaptations of the Vi-phage II. This phage was specific 
to the Vi capsular antigen of Salmonella enterica subsp. enterica Typhi (Felix, 1934). Most 
phage typing schemes use a panel of serologically distinct phages isolated from a myriad of 
sources. Such schemes have been put into place for Salmonella enterica serovars S. 
Paratyphi, S. Hadar, S. Virchow, S. Enteritidis and S. Typhimurium. The characterisation of 
the phages for the S. Enteritidis phage typing scheme showed that the 16 phages used come 
from three morphotypes, Podoviridae, Siphoviridae and Myoviridae (De Lappe, 2009). The 
S. Typhimurium scheme started by Felix and Callow (Felix, 1943) and then expanded by 
Anderson (Anderson, 1977) has distinguished over 300 phage types for S. Typhimurium. 
This subdivision into phage types allowed the quicker differentiation of emerging strains and 
allowed their impact and spread to be measured. 
 The vast majority of human salmonellosis cases are caused by subspecies 1, 70% by 
just 20 serovars (CDC, 2008). The low proportion of ‘problem’ serovars is likely the product 
of the lack of contact with other types and also their host specificity. Multilocus sequencing 
typing (MLST) has been used to show that bovine and human associated Salmonella isolates 
represent distinct and overlapping population (Alcaine et al., 2006). Of the 10 serovars most 
commonly isolated from human infections, 6 are found in the top 10 serovars isolated from 
both swine and poultry (Foley, 2008). 
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1.1.1 Salmonella nomenclature 
 
The nomenclature of Salmonella is complex as it has developed over time in response to 
diagnostic issues. For this report the scheme used by the Center for Disease Control will be 
followed (Brenner, 2000). Therefore the two species shall be cited as S. bongori or S. 
enterica and individual serovars shall be given either the full title of; Salmonella enterica 
subsp. enterica serovar Typhimurium or the shortened version of S. Typhimurium.  
1.2 Host specificity 
 
Different serovars of Salmonella display different levels of host specificity. The more host 
adapted strains, such as S. Gallinarum in poultry or S. Dublin in cattle (59% of cattle 
isolations in 2006 were S. Dublin (VLA, 2007)), are generally less pathogenic to humans, 
although there is some evidence that such infections can lead to more severe clinical 
symptoms. Between 1981 and 1990, 25% of human infections with S. Dublin developed 
septicaemia compared with 1-2% with the more common S. Typhimurium and S. Enteritidis 
infections (Threlfall, 1992). The two latter serotypes are the two most commonly isolated 
Salmonella isolates in humans. In the UK in 2000, S. Enteritidis accounted for 57% of 
Salmonella infections while S. Typhimurium accounted for 18% with the next highest 
contribution at 2% (WHO, 2003). By 2006 these two serovars still accounted for 66% of 
human isolations (VLA, 2007). During the 1980s there was a considerable increase in the 
number of human food-borne illness caused by S. Enteritidis; of 35 countries, 24 (69%) 
recorded an increase in S. Enteritidis isolates (Rodrigue, 1990).  
The prevalence of serotypes in outbreaks also seems to vary with region. In the US in 
2006 the top serovars in humans, responsible for over half of infections, were S. 
Typhimurium, S. Enteritidis and S. Newport. The serovars S. Typhimurium, S. Newport, S. 
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Agona and S. Orion were responsible for 38.3% of total isolations from farm animals 
showing clinical symptoms, while from non-clinical farm isolation (herd and flock 
monitoring, feed testing, environmental sampling etc) S. Heidelberg and S. Kentucky were 
the most commonly found (CDC, 2008). This is in contrast with the situation in Australia, 
where the top three human serovars for the same period were S. Typhimurium, S. Vichow and 
S. Saintpaul and from farm isolations S. Typhimurium, S. Dublin and S. Bovismorbificans 
(Powling, 2005). Variation within serovars is also apparent, in 2006 S. Newport accounted 
for 9% of UK cattle isolations and 1.7% of human isolations. However this serovar is of 
greater concern in the US where from 1996 to 2001 the human prevalence increased from 5% 
to 10% (Gupta, 2003). Normally isolated from cattle, Newport has emerged in the US as an 
issue affecting human health as it carries plasmids that confer antibiotic resistances and is 
developing resistances to later generation cephalosporins. In the UK, S. Newport does not 
demonstrate antibiotic resistance and has a variant pulsed field gel electrophoresis (PFGE) 
profile. 
1.2.1 Salmonella enterica subsp. enterica serotype Typhimurium 
 
S. Typhimurium (with the antigenic formulae 1,4,[5],12;i;1,2) is a zoonotic serotype 
commonly isolated from cattle although it is considered highly promiscuous as it is 
associated with disease or infection of a number of vertebrate species. It is associated with 
pyrexia, diarrhoea and in dairy cattle a drop in milk production (Sharp and Rawson, 1992).  
Over time certain phage types of S. Typhimurium have become predominant. During the 
1960’s multiple resistant phage type (PT) 29 became widespread in calves (Anderson, 1968). 
By 1977 PT204 and PT193 were most frequently isolated, with the variant definitive type 
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(DT) 204c 
1
 being the most common (Wray et al., 1998; Wray, 1987). Then in the late 80’s 
and early 90’s Salmonella Typhimurium DT104 emerged as a new epidemic strain.  
1.3 Epidemiology 
 
1.3.1 Initial colonisation 
 
Salmonella Typhimurium causes gastroenteritis in humans and farmed animal species 
including cattle and pigs, whereas in mice it has been shown to cause a systemic disease 
similar to typhoid fever, and is therefore a surrogate model for the study of systemic typhoid. 
The bacteria are ingested via contaminated food or water. In human volunteers the minimum 
infectious dose is approximately 10
6
, however single food outbreaks suggest that lower doses 
can cause disease. Bacteria that survive the low pH of the stomach locate to the lumen of the 
small intestine. In poultry, infected food reaches the crop, and subsequently the highest viable 
counts are found in the cecum, cloaca and ileum (Turner et al., 1998). 
The interaction of Salmonella with the host environment and the subsequent 
triggering of acute inflammatory reaction causes ileal secretion and diarrhoea (Giannella, 
1979). Interaction with protective cells such as polymorphonuclear leuocytes (PMN’s) and 
macrophages, and the production of prostaglandin, and subsequently adenylate cyclase leads 
to the fluid secretion. S. Enteritidis and S. Typhimurium have also been shown to disrupt 
gastro-intestinal epithelial tight junctions, which then may trigger ion efflux and diarrhoea. 
The structural damage caused by S. Typhimurium may also lead to the release of damaging 
oxidative compounds  
                                                 
1
 PT (phage type) and DT (definitive type) arise from phage typing naming schemes from different countries 
and should be considered equivalent. 
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In the murine model and in immunocompromised adults non-typhoidal Salmonella 
can also cause systemic infection. Persistence in the reticuloendothelial system with spread to 
the bone marrow, liver and spleen can then lead to bacteraemia (Gordon, 2008).  
1.3.2 Invasion 
 
In mice Salmonella principally invade the murine M cells, specialised epithelial cells which 
line the Peyer’s Patches of the intestine (Jones et al., 1994). The contact of Salmonella with 
the host cell membrane leads to changes in the brush border, with the microvilli becoming 
denatured. Membrane ‘ruffles’ begin to form and the bacteria are rapidly internalized inside a 
membrane bound vesicle (Jones et al., 1993). Distinct from other bacteria Salmonella remain 
inside the vesicle throughout the period of internalization.  The environment within the 
vesicle has been shown to contain lysine and oxygen and low concentrations of Mg
2+
 and 
Fe
2+
 and has a mildly acidic pH (Garcia-del Portillo, 1992). Internalised bacteria later exit 
through the basal surface into the reticuloendothelial system where they are readily engulfed 
by macrophages. 
Variations in the ability of different serovars to invade murine epithelia may be 
indicative of host specificity. S. Gallinarum is unable to invade murine M cells, while S. 
Typhimurium shows a greater ability to invade and persist then S. Typhi (Pascopella, 1995). 
The two avian adapted serovars S. Gallinarum and S. Pullorum can demonstrate increased 
invasiveness and the ability to cause membrane ruffles with mammalian cells when they are 
made to express S. Typhimurium type 1 fimbriae (Wilson et al., 2000). 
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1.3.3 Bacterial survival and general host defences 
 
Salmonella have to avoid many adverse conditions to survive within a host. Firstly the 
bacteria have to overcome innate defences. Salmonella are sensitive to deviations from a 
neutral pH, and thus the conditions present in the gut are generally detrimental to its survival.  
It has developed mechanisms to counter-act the environment. Low pH has been shown to 
trigger an acid tolerance response (ATR) in Salmonella and the increased expression of over 
50 proteins (Foster, 1991). Amongst these proteins are those that also offer some cross-
protection against acid shock, heat shock, osmolarity and H2O2. 
In addition Salmonella during the gastro-intestinal phase will have to face competition 
from the local micro flora for a limited amount of nutrients, low oxygen stress, IgA 
antibodies, bile salts and pancreatic enzymes. The physical presence of mucins may also 
protect the epithelial cells by preventing attachment of bacteria or contact with their toxins. 
One of the major host defence mechanisms that the bacterium can come into contact 
with is the complement system. Once through the mucosal membrane exposure to 
complement can lead to opsonization or the lysis of the cells. Some bacteria have a 
polysaccharide capsule (e.g. Salmonella Typhi – Vi capsule) which can prevent this while 
others including Typhimurium depend on the complete O antigen of the lipopolysaccharide 
on the outer surface to resist complement action (Joiner, 1988). Other mechanisms include 
TraT surface exclusion protein encoded by S. Typhimurium virulence plasmid (Rhen, 1988) 
and the Rck protein which confers high levels of complement resistance to S. Typhimurium 
by preventing the membrane attack complex (MAC) from inserting into the membrane 
(Heffernan, 1992). 
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1.3.4 Resistance to phagocytes 
 
There are several mechanisms by which bacteria can avoid being compromised by 
phagocytes such as macrophages. Firstly they can avoid being engulfed and thus stay in the 
extracellular environment. Should they be internalised they could escape from the phagosome 
or the fused phagosome-lysosome and then replicate within the ‘safe’ environment of the host 
cell cytoplasm, or they could prevent the fusion of the phagosome and lysosome. Finally they 
could persist inside the phagolysosome. S. Typhimurium demonstrates resistance to the 
oxidative and non-oxidative factors present in the macrophage (Alpuche-Aranda et al., 1994; 
Schwan et al., 2000). 
Mutation studies involving the use of Tn10 insertions and subsequent screening for 
survival in murine peritoneal macrophages have revealed mutations that affect auxotrophy, 
response to oxidative stress, LPS, motility and colony morphology. These mutations led to a 
reduced level of survival and avirulence (Fields, 1986).  
Oxidative or respiratory burst is one of the primary antibacterial functions of 
macrophages. It releases reactive oxidative intermediates (ROI’s) such as superoxide, 
peroxide, hydroxyl radicals and hypochlorous acid.  S. Typhimurium produces enzymes 
capable of neutralising ROI’s including two catalases for peroxide and superoxide dismutase 
(Farr, 1991). LPS also gives protection from macrophage produced defensins (murine 
macrophages do not produce these), lysozyme, cathepsin G, elastase, azurocidin and other 
proteases. Mutants with incomplete LPS have been shown to be highly susceptible to 
granular extracts of human PMN lysosomal fractions (Rest, 1977).  
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1.4 Molecular pathogenesis of Salmonella 
 
1.4.1 Plasmids. 
 
Virulence plasmids have been found in a few of the serovars of S. enterica subsp. enterica, 
including Typhimurium. These are between 50 and 90 kB in size and are important in 
multiplication in the reticulo-endothelial system of the host. The plasmid of Salmonella 
Typhimurium (identified from the strain LT2) contains a 7.8 kB region containing the spv 
(Salmonella plasmid virulence) region which is needed for virulence. It contains 5 genes in a 
regulon, spvRABCD. The plasmid also encodes a fimbriae gene, the pef locus. Plasmids have 
also been shown to carry antibiotic resistances, such as those found in US strains of S. 
Newport and in the plasmid HCM1 from S. Typhi (Doublet et al., 2004). 
 
1.4.2 Pathogenicity Islands. 
 
Salmonella can contain a series of pathogenicity islands that play roles in invasion, survival 
and proliferation during interactions with the host cell. The presence of Salmonella 
Pathogenicity Island 1 (SPI-1) provides the capacity to invade while SPI-2 gives the capacity 
for systemic spread. The distribution of these two pathogenicity islands within Salmonella 
has shown an evolutionary development, both S. bongori and S. enterica possess SPI-1, 
whilst only S. enterica possesses SPI-2 (Ochman and Groisman, 1996). Pathogenicity islands 
and islets are identified by the lower G+C content of their regions compared to the rest of the 
Salmonella genome. Currently 14 have been identified, although their contribution to 
virulence is still to be fully assessed by mutational inactivation and complementation studies 
(Morgan, 2007). 
SPI-1 is required by Salmonella for the invasion of host epithelial cells.  It comprises 
a 40kB region encoding a type three secretion system (TTSS), effector proteins and 
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transcriptional regulators (Mills, 1995). Studies have shown that the expression of this region 
is controlled by environmental cues in the intestinal tract and the control genes hilA and invF 
(Lucas, 2001; Mills, 1995; Schechter, 1999). The secreted effector proteins are encoded on 
the island by; avrA (antiflammatory inhibition of NFkB), sipA (preventing actin 
rearrangements), sipB (activating capsase 1, leading to apoptosis) and sopE and sopE2 
(activating Rho GTPases and cytoskeletal rearrangements). In addition the TTSS encoded by 
SPI1 can be used by proteins encoded by other pathogenicity islands.  
SPI-2 has been associated with intra-macrophage survival and systemic disease in the 
host (Groisman and Ochman, 1997; Hensel, 2000). It contains 44 open reading frames 
(ORFs) including ssrA/ssrB and a TTSS. In vitro Ca
2+
 and Mg
2+
 ions are lowered within 
macrophages by SPI-2.  SsrA/ssrB is a phosphor relay type sensor kinase. SPI-2 genes are 
needed for survival as they interfere in NADPH oxidase phagocyte dependent oxidative 
killing. SpiC is secreted into the macrophage cytosol and then prevents its fusion with the 
Salmonella containing phagosome. 
SPI-3 is a 17 kb region, containing the mgtCB operon. This can confer growth in 
Mg
2+ 
limited and intracellular environments. This is also involved in macrophage survival. 
Four other genes which encode cytoplasmic and putative membrane proteins are also present; 
rmbA, misL, fidL and marT. SPI-3 is regulated by a phoP/phoQ two component system. SPI-
4 encodes a type 1 secretion system (T1SS) and the protein SiiE. SiiE is a giant non-fimbrial 
adhesin which is involved in the adhesion of S. Typhimurium to epithelial cells and whose 
synthesis and secretion co-incides with the activation of invasion genes (Gerlach, 2007). SPI-
5 contains pipABCD and orfX. These are involved in host fluid and chloride secretion and a 
poor inflammatory response. 
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1.5 Virulence gene regulation 
 
The two component PhoP/PhoQ system has been implicated in the regulation of aspects of 
Salmonella virulence. The system controls more than 40 genes.  This system’s functionality 
is required for virulence in mice and humans, survival within macrophages, growth on 
succinate as a sole carbon source and growth in the presence of limited magnesium 
(Groisman, 2001). The PhoQ is a sensor histidine kinase that phosphorylates the response 
regulator PhoP in response to environmental signals. PhoQ activity is repressed by cations of 
magnesium and calcium. Phosphoylated PhoP activates pag (PhoP-activated) genes such as 
non-specific acid phosphatase, calcium transporters and outer membrane proteins. PhoP-PO4 
represses genes from SPI-1 including hilA and genes encoding the type III secretion system. 
The two component system is highly induced within non-spacious phagosomes, where low 
pH and low concentrations of Mg
2+
 and Ca
2+
 trigger its activation. PhoP null mutants exhibit 
increased sensitivity to cationic antimicrobial peptides (CAMPs). Genetic analysis of phoP 
regulon resulted in identification of pags that mediate resistance to specific CAMPs by lipid 
A modifications (Groisman, 2001).  
1.6 Drug resistance 
 
Multidrug resistant (MDR) S. Typhimurium definitive type 104 (DT104) was first isolated 
and characterised in the UK in 1984 (Threlfall, 1994). These strains commonly had the penta 
resistance profile ACSSuT, which confers resistance to ampicillin, chloramphenicol, 
streptomycin, sulfonamides and tetracycline. This resistance has been shown to be 
chromosomally encoded (Sandvang, 1998) and therefore relatively stable. It is therefore 
likely that even reduction in the use of antibiotics and therefore their selective pressure would 
not necessarily lead to a loss of the resistance, as may be the case with plasmid encoded 
resistance. In 1990, 259 cases of MDR DT104 human infections were recorded in the UK. By 
20 
 
1996 this had risen to 4006 cases (Threlfall, 1997). This was a greater rate of increase then 
with S. Enteritidis in the previous decade (Bäumler, 2000). Internationally DT104 has also 
been on the increase, in 1992 8.7% of S. Typhimurium strains isolated were identified as 
DT104, by 2001 this proportion had increased to 33% (Helms, 2005). 
 In a study of 83 cases of MDR DT104 infection, 41% of patients (34) required 
hospitalisation and 10 of them subsequently died, although other illnesses may also have 
contributed (Wall, 1994). Of further concern has been the acquisition of additional resistance 
in DT104. From less than 2% in 1993, the proportion of isolates resistant to trimethoprim has 
risen to 24% whilst resistance to ciprofloxacin has increased from 1% to 14% in the same 
time period (Threlfall, 1997). 
1.6.1 Salmonella Genomic Island 1 
 
The resistance genes in MDR DT104 are contained in a 43 kb region known as the 
Salmonella Genomic Island 1 (SGI1). This region has a G+C content of 49.17% compared to 
between 51 and 53% with the rest of the Typhimurium genome (Boyd et al., 2001). The 
region lies between thdF and a novel retron sequence and consists of 44 open reading frames. 
The multidrug resistant region lies between ORF 28 and ORF 42. This region has been 
sequenced and shown to contain integrons conferring resistances to ampicllin and 
sulphonomides (blaPSE1 and sul1) and to streptomycin and spectinomycin (aadA2) with 
plasmid derived genes for chloramphenicol/florfenicol (floR) and tetracycline resistance 
(tet(G)) in between  (Briggs, 1999; Lawson, 2004). Over time, different subclones of MDR 
DT104 with different resistance profiles have become more common (Threlfall, 2004). 
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The region outside of the multidrug resistance area has also been characterized. The 
genes from this region share similarity to plasmid genes involved in mating pair formation 
and DNA transfer. The putative products of ORF 5, ORF 11 and ORF 12 show similarity to 
the mating pair stabilization protein TrhN and pilus assembly proteins R0128 and TrhH from 
the IncH plasmid R27 found in S. Typhi (Boyd et al., 2001).  
The region is not self-transmissible (Boyd et al., 2001). However it has been shown to 
be an integrative mobilizable element (Doublet et al., 2005a). The ORFS between DR-L and 
ORF 3 have been characterized as being a putative integrase and a putative excisionase. 
 
1.7 Phage mediated evolution 
 
The Salmonella genome shows the presence of many chromosomally bound bacteriophage 
like, or ‘prophage’, regions (Cooke et al., 2007). It has been postulated that bacteriophages 
evolve in a ‘modular’ manner, exchanging whole sequences of DNA between themselves, 
while maintaining the genes that facilitate their transfer. They can be incorporated in the 
bacterial chromosome via transduction or lysogenic conversion. The global rate of phage 
mediated genetic modification in bacteria has been estimated up to 20 x 10
15
 gene transfer 
events per second (Brüssow, 2004). Virulence factors known to be encoded on phages 
include; Shiga toxin, ADP-ribosyltransferase toxins, LPS-modifying enzymes and type III 
effector proteins.  
Integrated bacteriophage regions have been identified in the S. Typhimurium genome 
(Cooke et al., 2007). They consist of 5 prophages; prophage 1(ST104), prophage 2(Gifsy-2), 
prophage 3, prophage 4 and prophage 5. Of these Gifsy-2 contains the genes; sseI, that codes 
for a type III effector protein, sodC-1, that codes for a superoxide dismutase and gtgE, which 
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has been hypothesised to have a role in virulence. The presence of phages within the bacterial 
genome is suggestive of a role they may have played in the development of the epidemic.  
1.8 Comparative genetics 
 
One of the drawbacks of traditional phenotypic characterisation of bacterial strains has been 
the difficulty in differentiating emerging infectious disease strains from others.. Grouping 
strains into phenotypically similar groups, i.e. through serotyping, does not necessarily reflect 
their genetic relatedness. Horizontal gene transfer of harmful genes, would generally be 
missed. 
Comparative genomic hybridization (CGH), using microarrays, has become a 
powerful tool for the interrogation of differences between closely related bacterial species. 
The fine level of genetic detail provided by microarrays and the ability to compare entire 
genomes significantly increases the chances of discovering genetic variability (Joyce, 2002). 
Salmonella has been a target for CGH microarray (Chan, 2003; Porwollik, 2004)
 
with 
comparisons made both between subspecies and within them. These studies have led to the 
identification of the core and variable components of S. enterica subspecies I (Anjum et al., 
2005). The core invariant component of Salmonella genome shows an 83% overlap with the 
conserved homologues within E. coli, including genes involved with cell motility, 
metabolism, signal transduction, transcription and translation. This finding shows the 
common evolutionary pathways which connect Salmonella and E. coli.  
The pathogenicity islands; SPI-1, SPI-2, SPI-3, SPI-4 and SPI-5, were shown to be 
conserved in all S. enterica subspecies I. Some variable regions identified are virulence 
determinants. Fimbriae, which are important in bacterial adherence to biotic and abiotic 
surfaces, are found throughout the strains. However only three fimbrial operons (fim, bcf and 
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stb) were conserved within the serovars examined. The CGH microarray method has 
therefore been demonstrated to be a valuable tool for considering the genetic make-up of 
Salmonella strains. 
1.9 Conclusion and testable hypothesis 
 
This brief introduction has given an overview of the biology and particularly the virulence 
factors of Salmonella enterica. Clearly alluded to, is the dynamic nature of the genome of 
Salmonella enterica with horizontal gene transfer by phage, plasmid and other mobile genetic 
elements playing a significant part in genome plasticity. Also cited above is the emergence of 
types that have come to the fore epidemiologically, which have a profound impact on human 
and animal health. It is interesting that types wax and wane to be replaced by the next 
emergent epidemic type. In simple terms, it may be envisioned that the emergence of a 
particular type may be due to a number of factors around the pathogen, the host and the 
environment. Given genome plasticity and our increasing knowledge of gene mobility, 
emergence may be through acquisition of new characteristics that provide some form of 
fitness advantage. There may be changes in host susceptibility such as through changing 
husbandry practices for animal management or immune naivety through subtle shifts in 
antigenicity of the infectious agent. In addition, there may be greater opportunities for 
infectivity through for example industrial food preparation and health care techniques, the 
global market and the rapid spread of pathogens across natural boundaries and climate 
change. In this study, I have attempted to find ways to explore possible reasons for the 
emergence of a particular type, namely S. Typhimurium DT104. Given the potential scope of 
such a study, I have focused down upon trying to ascertain what changes within DT104 may 
be associated with the epidemic. My testable hypothesis is that “DT104 emerged due to 
genetic changes that contributed to enhanced fitness”. An interesting corollary to that is that 
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the decline of DT104 may also be due to loss or alteration to those genetic changes. Thus, my 
study was framed by the attempt to understand the genetics and phenotype of strains 
representing the epidemic cycle through investigating pre-, mid and post-epidemic strains of 
DT104.  
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2 Materials and methods 
2.1 Bacterial strains 
 
The bacterial strains used are shown in Table 2-1. These were all isolated from human and 
animal sources from the United Kingdom. These span the period from 1986 until the present. 
This encompasses the understood period of the DT104 epidemic, late 80’s and throughout the 
90’s. They were isolated from individuals, both human and animal, suffering from 
salmonellosis. The animal strains came from species that come into contact with humans 
including bovine, porcine, avian and equine sources. Strains were sub-cultured from dorset 
egg slopes, provided by the Veterinary Laboratories Agency (VLA) and the Health Protection 
Agency (HPA), onto LB agar (Bertani, 1951) then further sub-cultured into LB containing 
30% glycerol to be stored at -80
o
C.  
In addition seven sequenced control strains; S. bongori and the Salmonella enterica 
strains; S. Enteritidis phage type 4 (PT4), S. Typhimurium LT2, S. Typhimurium SL1344 
(Wray, 1978) S. Gallinarum, S. Typhi CT18 and the sequenced S. Typhimurium DT104, are 
included. 
2.2 Slide Agglutination 
 
Strains were sub-cultured from glycerol stock into 3ml LB. These were then incubated at 
37
o
C overnight shaking at 150rpm. A 10µl loopful of phosphate buffered saline (PBS) was 
placed on a glass slide then a 10µl loop of the overnight culture to be tested was mixed in. 
Finally a 10µl loop of polyvalent O anti-sera was mixed in. Agglutination was identified by 
the formation of white ‘grains’ in the suspension. If a positive reaction to the polyvalent O 
anti-sera was seen then the procedure was repeated with the monovalent anti-sera that were 
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present in the polyvalent ant-sera that showed a positive response. By proceeding through a 
group of specific anti-sera the O antigen group can be identified. The process was repeated 
with a panel of H antigens (Jones, 2000). 
2.3 Antibiotic Minimum Inhibitory Concentration 
 
Following the validated British Society for Antimicrobial Chemotherapy (BSAC) method for 
minimum inhibitory concentration (Andrews, 2001) dilutions of 12 antibiotics (nalidixic acid, 
tetracycline, neomycin, ampicillin, ceftazidime, trimethoprim, chloramphenicol, gentamicin, 
streptomycin, cefotaxime, and ciprofloxacin) were prepared. Powdered antibiotic (Sigma) 
was weighed out and dissolved in the recommended solvent to a stock concentration of 
256mg/L inside a safety cabinet. The solutions were then diluted in a doubling dilution, i.e. 
by taking 10ml of stock and adding to 10ml doubled distilled water a 128mg/L solution was 
made. This was continued until a range of dilutions from 128mg/L to 0.125mg/L was made. 
These were stored at 4
o
C until used within the same 24 hour period. 
10ml of each antibiotic preparation was then introduced into 10ml of molten 
IsoSensitest agar equivalent (ISA: Oxoid, Basingstoke, UK). These were then poured into 
20ml plastic Petri dishes and left to set. The plates were then stored at 4
o
C until needed. 
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Table 2-1 Bacterial strains used for this study, including 32 S. Typhimurium DT104 test strains 
and the other Salmonella control strains included on the comparative genomic 
microarray 
 
 
ID Reference Serotype Phage type Isolation date Resistance type * Host 
S01 P4722210 Typhimurium DT104 1997 ACSSuSpT Human 
S02 P5416300 Typhimurium DT104 2001 ACSSuSpT Human 
S03 P4082900 Typhimurium DT104 1996 ACSSuSpT Human 
S04 P5289060 Typhimurium DT104 2000 SSp Human 
S05 P5224010 Typhimurium DT104 2000 ACSSuSpTTm Human 
S06 P5066840 Typhimurium DT104 1999 ACSSuSpTTmNxCp Human 
S07 P5358880 Typhimurium DT104 2001 ACSSuSpT Human 
S13 H0 4350 0377 Typhimurium DT104 2004 - Human 
S15 H0 4208 0120 Typhimurium DT104 2004 - Human 
S16 H0 4212 0222 Typhimurium DT104 2005 - Human 
S19 H0 4286 0471 Typhimurium DT104 2004 - Human 
S21 5252 0256 Typhimurium DT104 2005 SSuSp Human 
S22 5302 0351 Typhimurium DT104 2005 SSuSp Human 
S24 4322 0369 Typhimurium DT104 2004 SSuSp Human 
S27 P097747/0 Typhimurium DT104 1986 - Human 
S28 P097363/0 Typhimurium DT104 1986 - Human 
S29 P097482/0 Typhimurium DT104 1986 - Human 
S30 P097435/0 Typhimurium DT104 1986 - Human 
A01 L01470-06 Typhimurium DT104 2006 - Environmental 
A02 S06529-07 Typhimurium DT104 2007 - Equine 
D01 S01760/03 Typhimurium DT104 2003 ACSSuSpT Porcine 
D02 S05461/05 Typhimurium DT104 2003 SSu Porcine 
D03 S02442/05 Typhimurium DT104 2003 ACSSuSpT Porcine 
D04 B2436 Typhimurium DT104 2005 ACSSuSpT Poultry 
D05 B2455 Typhimurium DT104 2005 - Turkey 
D06 B2458 Typhimurium DT104 2005 - Bovine 
D07 1341/96 Typhimurium DT104 1996 ACSSuSpT Poultry 
D08 5085/98 Typhimurium DT104 1998 ACSSuSpT Poultry 
D09 6703/00 Typhimurium DT104 2000 ACSSuSpT Bovine 
D10 1041/96 Typhimurium DT104 1996 ACSSuSpT Porcine 
D11 1424/98 Typhimurium DT104 1998 ACSSuSpT Equine 
D12 3320/98 Typhimurium DT104 1998 ACSSuSpT Poultry 
S. bongori ATCC 43975 S. bongori - - - - 
LT2 ATCC 700220 Typhimurium - - - - 
SL1344 NCTC 13347 Typhimurium - - - - 
DT104 NCTC 13348 Typhimurium DT104 - ACSSuSpT - 
PT4 NCTC 13349  Enteritidis PT4 - - - 
S. Gallinarum NCTC 13346  Typhimurium DT104 - - - 
CT18  - Typhi - - ACSuTmT - 
 
* Ampicillin (A), Cholamphenicol/Floramphenicol (C), Ciprofloxacin (Cp), Nalidic Acid (Nx), Spectinomycin (Sp), Steptomycin 
(S),  Sulphonamides (Su),  Tetracycline (T),  Trimethoprin (Tm) 
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Strains were sub-cultured from glycerol stock into 3ml LB. These were then 
incubated at 37
o
C overnight and at 150rpm. The strains to be tested were diluted to 10
4
 
CFU/ml. The plates were dried for 30mins at 37
o
C. Corrected culture were stamped with a 
multipoint inoculator onto the dried plates, these were left for 48 hours in an incubator at 
37
o
C.  
2.4 Multilocus Sequence Typing (MLST) 
 
All the test strains plus the sequenced DT104 strain underwent MLST screening. The strains 
were sub-cultured from glycerol stocks onto LB agar and incubated at 37°C overnight. DNA 
was isolated by harvesting the overnight cultures into 900μl of 0.1 M phosphate buffered 
saline (PBS). These were boiled at 100°C for 10mins before being centrifuged at 13,000 
RPM (in a Microfuge) for 10mins. The supernatant was removed into sterile eppendorfs. 
Primers for the 7 housekeeping genes from the Salmonella MLST database 
(http://web.mpiib-berlin.mpg.de/mlst) were acquired from Eurofin MWG Operon: thrA 
(aspartokinase, homoserine dehydrogenase), purE (phosphoribosylaminoimidazole 
carboxylase), sucA (α-ketoglutarate dehydrogenase), hisD (histidinol dehydrogenase), aroC 
(chorismate synthase), hemD (uroporphyrinogen III cosynthase) and dnaN (DNA polymerase 
III β subunit).  
Polymerase chain reactions (PCR) were carried out for each sample for the 7 genes. 
1μl of DNA lysate was used with 2μl of each respective primer and 45μl of Abgene 
mastermix containing ThermoPrime Taq DNA polymerase. The PCR cycling conditions are 
listed in Table 2-2 and the PCR primers are listed in Table 2-4. Reactions were carried out 
over 35 cycles on a GeneAmp® PCR System 9700, (Applied Biosystems). 
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Table 2-2 PCR cycle conditions for initial amplification of the 7 housekeeping genes 
Temperature   Mins No. Cycles 
95°C 3.00  
94°C 0.20  
50°C 0.20 35 
72°C 1.00  
72°C 5.00  
4°C ∞  
 
The initial products of the amplification were cleaned up using the Qiagen Mini Elute 
PCR Purification Kit (Qiagen, cat. no. 28006). Each product then had its DNA concentration 
estimated using a Labtech International Nano Drop ND-1000 spectrophotometer and run on 
an 1.5% agarose gel to check quality of the product. Those with clear bands of the expected 
size were then used for the sequencing reaction using BigDye Terminator Ready Reaction 
Mix v3.0 containing AmpliTaq
®
 DNA Polymerase (Applied Biosystems), the conditions 
listed in Table 2-3 and the sequence primers listed in Table 2-5 were carried out over 30 
cycles on a GeneAmp® PCR System 9700, (Applied Biosystems). 
Table 2-3 Sequencing reaction cycle conditions for the cleaned up products of the initial PCR 
Temperature   Mins No. Cycles 
96°C 3.00  
96°C 0.10  
50°C 0.05 
X 
30 
60°C 2.00  
4°C ∞  
 
Once the sequencing reaction was finished the reactions were stored at 4°C for a 
maximum of 24 hours. The reactions were cleaned up as follows. Each was transferred to a 
1ml eppendorf. Independently 280μl of 3M sodium acetate (pH 4.6) was added to 7ml of 
100% ethanol at room temperature. This was vortexed for 30 secs. 52μl of this mixture was 
added to each sample and vortexed. Samples were incubated in the dark at room temperature 
for 45mins. They were then centrifuged at 15,000 RPM at 4°C, the supernatant was discarded 
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and the pellets washed with 150μl of ice cold 70% ethanol. A further spin at 15,000 was 
carried out and the supernatant removed as before. Pellets were dried on the bench top at 
room temperature until all ethanol had evaporated, they were then sealed with nescofilm, 
packaged and sent for sequencing to the Sequencing Facility Department, University of 
Oxford. 
Completed sequences were processed with the Lasergene SeqMan program from 
Dnastar, Inc. Sequences were proof read and trimmed to the correct fragment size. The 
completed sequences were then saved in a fasta format and submitted to the MLST database 
at the MPI für Infektionsbiologie website (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Senterica) to acquire the sequence type. 
 
Table 2-4 Primer pairs used for the initial PCR amplification of internal fragments of the 7 
houskeeping genes  
Gene Sequence Product length 
thrA: F  5'-GTCACGGTGATCGATCCGGT-3' 852 bp 
thrA: R  5'-CACGATATTGATATTAGCCCG-3'  
purE: F 5'-ATGTCTTCCCGCAATAATCC-3' 510 bp 
purE: R 5'-TCATAGCGTCCCCCGCGGATC-3'  
sucA: F 5'-AGCACCGAAGAGAAACGCTG-3' 643 bp 
sucA: R 5'-GGTTGTTGATAACGATACGTAC-3'  
hisD: F 5'-GAAACGTTCCATTCCGCGCAGAC-3' 894 bp 
hisD: R 5'-CTGAACGGTCATCCGTTTCTG-3'  
aroC: F 5'-CCTGGCACCTCGCGCTATAC-3' 826 bp 
aroC: R 5'-CCACACACGGATCGTGGCG-3'  
hemD: F 5'-ATGAGTATTCTGATCACCCG-3' 666 bp 
hemD: R 5'-ATCAGCGACCTTAATATCTTGCCA-3'  
dnaN: F 5'-ATGAAATTTACCGTTGAACGTGA-3' 833 bp 
dnaN: R 5'-AATTTCTCATTCGAGAGGATTGC-3'  
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Table 2-5 Primer pairs for sequencing reactions carried out on the products of the initial PCR 
 
Gene Sequence 
thrA: sF  5'-ATCCCGGCCGATCACATGAT-3' 
thrA: sR  5'-CTCCAGCAGCCCCTCTTTCAG-3' 
purE: sF  5'-CGCATTATTCCGGCGCGTGT-3' 
purE: sF1  5'-CGCAATAATCCGGCGCGTGT-3' 
purE: sR  5'-CGCGGATCGGGATTTTCCAG-3' 
purE: sR1  5'-GAACGCAAACTTGCTTCAT-3' 
sucA: sF  5'-AGCACCGAAGAGAAACGCTG-3' 
sucA: sR  5'-GGTTGTTGATAACGATACGTAC-3' 
hisD: sF  5'-GTCGGTCTGTATATTCCCGG-3' 
hisD: sR  5'-GGTAATCGCATCCACCAAATC-3' 
aroC: sF  5'-GGCACCAGTATTGGCCTGCT-3' 
aroC: sR  5'-CATATGCGCCACAATGTGTTG-3' 
hemD: sF  5'-GTGGCCTGGAGTTTTCCACT-3' 
hemD: sF1  5'-ATTCTGATCACCCGCCCCTC-3' 
hemD: sR  5'-GACCAATAGCCGACAGCGTAG-3' 
dnaN: sF  5'-CCGATTCTCGGTAACCTGCT-3' 
dnaN: sR  5'-CCATCCACCAGCTTCGAGGT-3' 
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2.5 Comparative Genomic Hybridisation (CGH) 
 
The previously indicated strains (Table 2-1) were compared using a whole genome array 
designed by the Sanger Institute, Cambridge (Thomson et al., 2004). It consists of specific 
unique PCR products, ranging in size from 200 – 500 bases from the S. Typhi CT18 genome, 
with the addition of specific PCR products from a further 6 strains representing different 
serovars.  The control strains contribution to the array is outlined in Table 2-6. Positive and 
negative controls such as cy3 and genes fragments from the Arabidopsis genome were 
included on the slides. Each product was replicated at least 4 times on each individual slide. 
Table 2-6 Source and of genes present of microarray slide. 
 
Serovar / strain Number of genes 
S. Typhi CT18 4097 
S. Gallinarum 83* 
S. Typhimurium, LT2 397* 
S. Typhimurium, SL1344  136* 
S. Typhimurium, DT104 126* 
S. Enteritidis, PT4 147* 
S. bongori 539* 
* Numbers indicate the unique genes from the six 
representative serotypes 
 
The bacteria were cultured in LB broth overnight at 37°C and at 150 rpm in a shaking 
incubator. DNA was extracted using the Qiagen DNeasy
®
 Blood & Tissue Kit (Qiagen cat 
no. 60504). 2μg of control DNA mix consisting of the 7 strains included on the array, and 
2μg test DNA were labelled with fluorescent cyanine dyes Cy5 and Cy3 respectively, using 
the Invitrogen BioPrime DNA labelling System Kit (Invitrogen cat. no.18094-011). Labelled 
DNA was purified using the Qiagen MiniElute PCR Purification Kit (Qiagen cat. no. 28004). 
Dye incorporation was measured using a Labtech International Nano Drop ND-1000 
spectrophotometer. A dye incorporation value of 80-100pmol/µl was required to continue 
with the assay.  
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The purified DNA was precipitated using 1/10th the volume of 3M NaAc pH 5.2 
(SIGMA, cat. no. S7899) and 3 times the volume of room temperature 100% ethanol.  The 
mixture was incubated at -70°C for 20mins to precipitate then centrifuged at room 
temperature for 10min at 13,000 rpm.  The supernatant was discarded and 100µl of 70% 
ethanol was added. After a further centrifuge step of 5mins, the supernatant was removed by 
aspiration and air dried for 5mins.  The DNA was resuspended in 30µl of hybridization buffer 
(5x sodium chloride sodium citrate (SSC), 6x Denhardt’s reagent, 60mM TrisHCL pH 7.6, 
0.12% sarkosyl; SIGMA; filter sterilized) and 6µl of tRNA (from yeast, SIGMA cat. no. 
R8508).  
The Hybridization / DNA solution was heated at 95 °C for 2mins and cooled for 
approximately 10mins at room temperature.  The hybridization buffer was then added to the 
middle of an inverted clean 60x25mm cover slip (VWR International cat. no. 631-0167). The 
microarray slide was gently lowered onto the cover slip to prevent bubbles and misplacement. 
The microarray slides were incubated in a hybridization chamber at 65 °C for 16-20 hours.  
The cover slip was removed by submerging in 65
 
°C washing buffer A (20xSSC, 20% 
sodium dodecyl sulphate (SDS); Sigma). The slide was then washed in washing buffer A for 
2mins and transferred to washing buffer B (20xSSC; Sigma) for another 2mins, and washed 
twice.  The slide was placed in 50 ml centrifuge tube and centrifuged at 1,500 rpm for 
10mins. 
Cy3/Cy5 fluorescent images of microarray slides were scanned by using Genepix 
4000B scanner (Axon Instruments, Inc.).  The obtained images were quantified with Genepix 
Pro software (Axon Instruments, Inc.)  Signal intensities were corrected by subtracting the 
local background. Where only the control DNA has hybridized the Cy5 shows red, where 
both test and control DNA has hybridized a yellow spot appears.  
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Spots with a value for median signal intensity minus the background below 50 (in 
both the control and test channel) were discarded due to low signal intensity that could lead to 
ambiguous results. Per spot per chip intensity-dependent Lowess normalization was 
performed to compensate for unequal dye incorporation. The ln(Cy3/Cy5) ratio intensity of 
all spots from the hybridization was calculated and the mean ln(Cy3/Cy5) from up to eight 
data points per gene (i.e. two slides with four repeats per slide), was used in all subsequent 
data analyses. The relationship between strains was calculated by average-linkage 
hierarchical clustering using the Pearson Correlation as part of the GeneSpring microarray 
analysis software V5.0 (Silicon Genetics). Exact cut-offs for present/absent genes are often 
inaccurate for microarray data, therefore the presence/conserved or absence/divergent nature 
of each gene was calculated by the final calculation ln(Cy5/Cy3) ratio intensity of the 
normalized data.  The present/absent genes were displayed in GeneSpring by giving a 
standard GeneSpring coloured representation. Those genes that can be considered to be 
absent/divergent in this experiment with the greatest degree of certainty lie at the blue end of 
the scale, around an ln(Cy5/Cy3) ratio of 0. Those genes that are present/conserved with the 
greatest degree of certainty lie in the yellow region and have a ln(Cy5/Cy3) ratio of around 1. 
The red end of the scale indicates an increased hybridization with the test strain and may be 
to due to presence of genes with multiple copies. 
2.6 PCR for artA/B presence in strains 
 
Using the identified artA/B toxin region in DT104 (Saitoh, 2005) and the sequence of DT104 
available (Dougan) PCR primer pairs were designed for S. Typhimurium DT104 genes artA, 
artB, and a bridging region covering artA and artB. The PCR cycling conditions used are 
listed in Table 2-7. PCR primer pairs are listed in Table 2-8. DNA was extracted using the 
Qiagen DNeasy
®
 Blood & Tissue Kit (Qiagen cat no. 60504). 
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Table 2-7 PCR cycle conditions for amplification of the ArtA/B region 
 
Temperature   Mins No. Cycles 
95°C 3.00  
94°C 0.20  
50°C 0.20 35 
72°C 1.00  
72°C 5.00  
4°C ∞  
 
   
   
2.7 Sequencing 
 
To investigate possible variations with the artA/B region a sequencing study was carried out. 
Using the identified artA/B toxin region in DT104 (Saitoh, 2005) and the sequence of DT104 
available (Dougan) primers were designed to encompass the entirety of the artA and artB 
genes, giving a predicted product size of 1380bp (Table 2-8). DNA was extracted using the 
Qiagen DNeasy
®
 Blood & Tissue Kit (Qiagen cat no. 60504). The PCR cycling conditions 
were used as in Table 2-7. Sequencing primers are listed in Table 2-8. PCR products were 
sent to the Veterinary Laboratories Agency sequencing department for processing. Returned 
sequences were processed with SeqMan and analysed with MegAlign, both programs from 
the DNASTAR Lasergene suite of applications. 
 
 
Table 2-8 PCR primer pairs for amplification of areas within the pertussis toxin region 
 
Gene Sequence Product length 
artA/B bridge F 5'-GTAAGTACCCGGGAAAGGATT -3' 417 bp 
artA/B bridge R 5'- ATACACGCCATAAGACAGATTG-3'  
artA F 5'-GAGACCTCCGGATGTGATTTTC -3' 465 bp 
artA R 5'-ACCCCAGGATTTGATTGTGTA -3'  
artB F 5'-GCTCTTACTCTTGCGTCGTT -3' 388 bp 
artB R 5'-TAGGTCCCATACAATAATCT -3'  
artA/B seq F 5’-GGTGGCTTGCCTGATAGTT-3’ 1380 bp 
artA/B seq R 5’-ACATAATCGTCTCACCAACAAG-3’  
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2.8 Phenotypic MicroArray™. 
 
The growth phenotypes of the DT104 test strains were assessed using the Phenotypic 
MicroArray™ system from Biolog, Inc., utilising plates PM1, PM2a, PM3b and PM4a. These 
are 96 well microtitre plates each containing a defined medium with the addition of sole 
carbon sources (PM1 and PM2a), sole nitrogen sources (PM3b) or sole phosphorus and 
sulphur sources (PM4a). In addition, to each well was added tetrazolium violet which is an 
indicator of respiration when it is reduced. PM1 and PM2a contain 190 carbon sources (with 
ammonium as a nitrogen source), PM3b contains 95 individual nitrogen sources and PM4a 
contains 59 phosphorus and 35 sulphur sources. To these last two plates succinate was added 
as a carbon source, with the inoculating fluid (see below).  
Firstly a carbon solution stock of 2M sodium succinate and 200 μM ferric citrate (pH 
7) was prepared (Table 2-9). The solution was sterilized by filtering through a 0.8 µm filter 
and stored at in 5 ml aliquots at 4
o
C. 10 ml of IF-0 (inoculating fluid, no carbon, Biolog, Inc.) 
was aliquoted into a 150 mm sterile capped test tube for each strain being prepared. The 
strains were grown on a LB agar plate by streaking the bacterium from isolated colonies and 
allowing it to grow overnight at 37°C. If the cells were streaked from a frozen glycerol stock, 
they were sub-cultured a second time. Cells were taken from the LB agar plate using a sterile 
swab and transferred into the sterile capped tube containing 10ml of IF-0. The cell suspension 
was stirred with the swab and then inverted to obtain a uniform suspension. The turbidity of 
the suspension was checked with the Biolog, Inc Turbidimeter and cells or IF-0 added to 
achieve 85% T (transmittance).  
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Table 2-9 Preparation of carbon source for Phenotypic MicroArray, 
for plates PM3b and PM4a. 
 
Carbon Source Formula Weight Per 100 ml 
2 M sodium succinate 270.1 54.02 g 
200 µM ferric citrate 244.9 4.9 mg 
 
 
Independently the inoculating fluids used for inoculating phenotype array panels were 
prepared as follows (Table 2-10). 100µl of the relevant inoculating fluid was added to each 
well of the plates.  The inoculated plates were then placed inside the OmniLog™ incubator 
and incubated for 30 hours at 37°C. The OmniLog™ software recorded the level of colour 
change every 15mins. Kinetic data was analyzed with the OmniLog™ – Pm software version 
OL_PM_FM/Kin 1.30, and imported into Microsoft Excel. 
 
Table 2-10 Preparation of inoculating fluid for Biolog plates. 
 
Ingredient PM 1 – 2a PM 3b – 4a 
IF-Base 10 ml (IF0A) 10 ml (IF0A) 
Dye Mix A 100X 0.12 ml 0.12 ml 
Carbon Source 
(200mM) 
- 0.12 ml 
cell density  85%T 0.12 ml 0.12 ml 
Thiamine* 0.003 ml 0.003 ml 
Sterile water 1.76 ml 1.64 ml 
Final Volume 12 ml 12 ml 
   
 
2.9 Growth rate assay 
The growth of the strains in minimal medium was measured by reading the OD600 every 
30mins over 240 cycles, for a total of 120 hours, using the FLUOstar Optima automated 
microplate based multi-detection reader (BMG Labtechnologies, Offenburg, Germany). 
S.Typhimurium LT2 and S. Gallinarum were included as control strains. 
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Inoculating cultures were grown from glycerol stocks into 3ml LB broth, at 37
o
C 
shaking at 150 rpm overnight. MOPS minimal medium (Neidhardt, 1974) was used in the 
preparation of the test media (Table 2-11). The standard assay uses 0.4% glucose (w/v) final 
concentration and this was replaced by compounds highlighted by the Phenotypic 
MicroArray study, either 20% glyoxylate or tartaric acid; in addition LT2 grown in glucose 
was used as a reference strain. 
Table 2-11 Inoculating fluid preparation for FLUOstar assay. 
 
Medium A Medium B 
Reagent Volume / µl Reagent Volume / µl 
MOPS 1000 MOPS 1000 
K2HPO4 100 K2HPO4 100 
H2O 8700 H2O 8700 
20% Glucose 200 20% Glyoxylate or Tartaric acid 200 
Total 10000 Total 10000 
    
 
 
   
1498.5µl of chosen medium for each strain to be tested was aliquoted into labelled 
eppendorf tubes. To this 1.5µl of overnight culture was added and was mixed by pipetting to 
give ≈ 1x105 cells. 200µl of the medium/strain mix was added to at least 3 wells of an 96 well 
plate from IWAKI
®
. This was then placed in the FLUOStar Optima reader. 
Growth of the strains was measured for glyoxylate concentrations of 0.2, 0.4, 0.8% 
(w/v) final concentration and with tartaric acid at 0.1, 0.2, 0.4, 0.8, 1.6, and 3.2% (w/v) final 
conc. These concentrations encompass those present on the Phenotypic MicroArray plates. 
The FLUOstar machine took OD readings every 900secs for 150–240 cycles, to cover the 
growth up to stationary phase. Data on growth is outputted into an Excel spreadsheet for 
processing. 
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2.10 Macrophage persistence study 
 
A tissue culture assay was carried out to measure the persistence of some of the strains inside 
macrophages. Preliminary tests were carried out with two cell lines. The Murine RAW 264.7 
and human U937 macrophages were tested. Initial optimisation showed more consistant 
results with the human cell line and therefore this line was chosen to move forward with. 72 
hours prior to infection cells were seeded into 24 well plates at 2x10
5
 cells ml
-1
. The strains 
chosen were sub-cultured into 20ml LB broth and left shaking at 150rpm at 37°C overnight. 
Overnight cultures were centrifuged at 13,000 rpm for 10mins, washed with 10ml 0.1M PBS 
and then re-spun at 13,000 rpm. Washed cultures were re-suspended and corrected to an 
OD600 of 1.2 with the addition of further PBS. 
Dulbecco's Modified Eagle Medium (DMEM, Sigma) culture medium with 1% L-
Glutamine (Sigma) and 1% essential amino acids (Sigma) was prepared. Bacterial suspension 
was added to prepared culture medium (500μl to 9.5ml of medium) to give a final 
concentration of bacteria of ≈ 2x107 colony forming units (c.f.u.) ml-1. 1ml of this suspension 
was added to the tissue culture wells in triplicate, giving a multiplicity of infection ratio of 
1:100. The plates were then left at 37°C in a 5% CO2 incubator for 2 hours. 
After 2 hours one plate was washed 2x with Hanks Balanced Salt Solution (BSS, 
Sigma) then the cells were lysed with 0.1M PBS containing 1% Triton (Sigma). Supernatant 
from this plate then underwent a dilution series and was plated out for colony counting. The 
other plates were washed 3x with Hanks BSS. 1ml of fresh culture medium containing 
100μg/ml-1 of gentamicin was then added to each well, and the plates left incubating. Plates 
were when removed at different time points (5 hours or 24 hours). They were then washed 
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and lysed with 0.1M PBS containing 1% Triton (Sigma).  Supernatant from this plate then 
underwent a dilution series and was plated out for colony counting. 
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3 Characterisation of strains 
The bacterial test and control strains chosen for this study are listed in the method chapter in 
Table 2-1. The test strains were isolated from humans suffering from salmonellosis (18 
strains) and from animal hosts (14 strains) from the United Kingdom. They span the period 
from 1986 through to 2007. This time frame encompasses the understood period of the S. 
Typhimurium DT104 epidemic, from the late 1980’s and through the 1990’s. Therefore, this 
strain selection should permit the investigation of genetic changes that may have taken place 
during this period. 
As well as time and host species, another factor taken into account for strain selection 
was the antibiotic resistance profile. Resistance in DT104 was first reported at the beginning 
of the epidemic period (Threlfall, 1994). Strains chosen from the pre-epidemic period were 
generally sensitive to antibiotics. Strains from the epidemic period have the ‘typical’ penta 
resistance profile ACSSuT, however, variant resistance profiles as well as fully sensitive 
profiles were also observed during the epidemic. A selection of strains reflecting this 
diversity was chosen. In the post-epidemic period, strains showed both sensitivity and 
resistance and so a further selection of strains was made from this period. Overall 20 of the 
strains showed differing degrees of antibiotic resistance while 12 were completely sensitive. 
The previous paragraph posed a testable hypothesis that the strains arising from the epidemic 
were likely to show genetic changes probably associated with the rise and fall of the 
epidemic. The evidence of varying resistances from fully sensitive, to resistant, to sensitive 
again was preliminary evidence to suggest the hypothesis was potentially sound. 
The test strains were provided by the Health Protection Agency (HPA) and the 
Veterinary Laboratories Agency (VLA) as cultures on Dorset egg slopes. They were sub-
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cultured onto the nutrient rich Luria-Bertani (LB) agar (Bertani, 1951) then further sub-
cultured in triplicate into LB broth containing 30% glycerol to be stored frozen at -80
o
C for 
long term storage. An issue that had to be considered was the effect that prolonged storage at 
low temperature and repeated thaw and re-freezing could have on the genetic make-up of the 
strains. Bacterial survival processes may lead to genetic changes that would mask or replace 
any differences that may exist in the initial isolates.  Given this concern, it was important to 
demonstrate that strains selected for study still conformed to the data (serotype, phagetype 
and resistance profile) ascribed to each strain on initial storage.  
Furthermore, additional genetic tests such as PFGE and MLST can be used to assess 
relatedness. Relatedness of course assumes that we are dealing largely with a single clonal 
type that has acquired resistances and possibly other genetic changes over the period of the 
epidemic. 
In addition, seven control strains were provided by the VLA and the Wellcome Trust 
Sanger Institute, Welcome Trust Genome Campus, Hinxton, Cambridge. These were: S. 
bongori and the Salmonella enterica strains; S. Enteritidis phage type 4 (PT4), the S. 
Typhimurium strains LT2, SL1344 and DT104, S. Gallinarum and S. Typhi CT18. These 
were sub-cultured and stored in the same manner as the field isolates. The seven control 
strains have had their genomes sequenced, and this information and their annotations are 
available from GenBank and the Sanger Institute website. S. bongori ATCC43975 (Sanger 
Institute) (Dougan), S. Enteritidis P125109 (GenBank AM933172) (Thomson et al., 2008), S. 
Typhimurium DT104 NCTC13348 (Sanger Institute) (Dougan), S. Typhimurium LT2 
(GenBank AE006468) (McClelland et al., 2001), S. Typhimurium SL1344 NCTC13347 
(Sanger Institute) (Dougan)  S. Gallinarum 297/91 (GenBank AM933173) (Thomson et al., 
2008), S. Typhi CT18 (GenBank AL513382) (Parkhill et al., 2001). 
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3.1 Preliminary characterisation 
 
3.1.1 Serotyping 
 
To confirm the designation of the test strains as Salmonella Typhimurium DT104 slide 
agglutination and phage typing were carried out. All test strains were confirmed as being 
Salmonella Typhimurium via slide agglutination, with the Kauffmann-White serotype 
1,4,[5],12;i;1,2. The O-antigens O4, O5 and O12, and phase 1 H-antigen i and phase two H-
antigens 1 and 2 were detected.  Phage typing was carried out in conjunction with the VLA 
Salmonella reference laboratory within the Food and Environmental Safety Department, and 
the strains were confirmed as being definitive type 104. Both these characterisations were 
repeated periodically throughout the study to confirm that no contamination had occurred. 
3.1.2 Antibiotic resistance 
 
The evolution of antibiotic resistance within Gram negative bacteria has become an issue of 
increasing importance, with implications for the treatment of disease in animals and humans. 
Numerous tests and methodologies have been developed to ascertain quickly and apply 
quantitative values to such resistances. Therefore the antibiotic profiles associated with the 
test strains were confirmed with an antibiotic MIC following the scheme developed by the 
British Society for Antimicrobial Chemotherapy (BSAC). The thresholds acquired from the 
test fell within the expected values provided by the ‘BSAC Methods for Antimicrobial 
Susceptibility Testing’ Version 5, February 2006’ (Andrews, 2006). The results, displayed in 
Table 3-1, confirmed the antibiotic resistance profiles of the test strains that had been 
assigned to them before the study Table 2-1. 
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3.2 Further characterisation 
 
3.2.1 Multilocus Sequencing Typing (MLST) 
 
Multilocus sequence typing was used to discriminate between strains by looking at the 
changes in bases within stable chromosomal housekeeping genes, as it allows an insight into 
the evolutionary development of strains and their relationships to each other. The MLST 
scheme for S. Typhimurium takes advantage of 7 housekeeping genes (Anderson, 1977) (see 
methods) and has classified the strains as shown below in Table 3-2 and in Figure 3-1.  
The DT104 strains were generally assigned the sequence type ST19. The exceptions 
to this being stains S15 and A02, which had the sequence type ST36 and strains A01 and D02 
which had independent unknown sequence types.  
The database of submitted strain information at the Max-Planck-Institut für 
Infektionsbiologie website (http://web.mpiib-berlin.mpg.de/mlst/dbs/Senterica) shows 230 
Typhimurium strains with the associated ST19 type and only 3 with the ST36. Of the listed 
ST19 strains; 116 have no phage type assigned, 45 are DT104, 7 are DT193, 12 are DT204, 
10 are DT99, 4 are DT49 and there are miscellaneous others. 
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Table 3-1 Antibiotic minimum inhibitory concentrations for the 30 test strains for a panel of 12 antibiotics. The BSAC standards for each antibiotic is listed 
at the top of the table, and the level at which no further growth was observed for each of the test strains is listed below. If the value at which no 
growth was noted is greater that the BSAC standard then the strain was considered ‘resistant’ to that antibiotic
 Antibiotic mg/L 
 Nalidixic Acid Streptomycin Tetracycline Neomycin Gentamicin Sulfadiazine Ampicillin Ceftotaxime Ceftazidime Chlorophenicol Trimethoprim Ciprofloxacin 
BSAC 
standard *>128 8 1 - 4 32 16 2 8 8 0.12 0.015 
Strain               
S01 128 >128 >128 4 1 >128 >128 0.5 8 >128 0.25 <0.125 
S02 128 >128 >128 8 2 >128 >128 0.5 4 >128 0.25 <0.125 
S03 128 128 >128 4 1 >128 >128 0.25 8 >128 0.25 <0.125 
S04 128 128 4 4 1 2 2 0.25 4 16 0.125 <0.125 
S05 128 128 >128 4 1 >128 >128 0.25 4 128 16 <0.125 
S06 >128 >128 >128 4 1 >128 >128 0.5 4 >128 8 0.25 
S07 128 128 >128 4 1 128 >128 0.25 4 >128 0.25 <0.125 
S13 128 16 4 4 1 16 4 0.5 4 4 0.125 <0.125 
S15 128 16 4 4 1 16 1 0.25 4 4 0.125 <0.125 
S16 128 32 4 4 1 8 2 0.5 4 4 0.25 <0.125 
S19 128 16 4 4 1 8 4 0.5 4 4 0.125 <0.125 
S21 128 >128 4 4 1 >128 2 0.5 4 4 0.125 <0.125 
S22 128 >128 4 8 1 >128 2 0.5 4 8 0.125 <0.125 
S24 128 >128 4 4 1 >128 4 0.25 4 4 0.25 <0.125 
S27 128 32 4 8 2 16 4 0.5 4 4 0.125 <0.125 
S28 128 32 4 4 1 16 2 0.25 4 4 0.25 <0.125 
S29 128 16 4 4 1 8 4 0.5 4 4 0.25 <0.125 
S30 128 32 4 4 4 16 2 0.5 4 8 0.125 <0.125 
A01 128 2 4 4 1 4 2 0.25 4 4 0.125 <0.125 
A02 128 2 4 4 1 4 2 0.25 4 4 0.125 <0.125 
D01 128 >128 >128 4 1 >128 128 0.25 4 >128 0.125 <0.125 
D02 128 >128 4 4 1 >128 4 0.25 4 4 0.125 <0.125 
D03 128 >128 >128 4 1 128 >128 0.5 4 >128 0.125 <0.125 
D04 128 >128 >128 4 1 128 >128 0.25 4 >128 0.125 <0.125 
D05 128 2 2 4 1 4 2 0.25 4 4 0.125 <0.125 
D06 128 1 4 4 1 8 2 0.25 4 4 0.125 <0.125 
D07 128 >128 >128 8 1 >128 >128 0.5 4 >128 0.25 <0.125 
D08 128 >128 >128 4 1 >128 >128 0.25 4 >128 0.25 <0.125 
D09 128 >128 >128 4 1 >128 >128 0.25 4 >128 0.125 <0.125 
D10 128 >128 >128 4 1 128 >128 0.25 4 >128 0.125 <0.125 
D11 128 >128 >128 4 1 >128 >128 0.25 4 >128 0.125 <0.125 
D12 128 >128 >128 4 1 >128 >128 0.5 4 >128 0.125 <0.125 
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The comparative rareness of strains with the ST36 type may be an indication 
of either their infrequent isolation, perhaps due to a different host reservoir or a lower 
incidence of clinical symptoms, or may be indicative of their more recent emergence. 
The same rationalization can be used for unknown ST types of strains A01 and D02.  
An interesting observation was the two strains A01 and D02 that had an 
unknown MLST ST type were similar to ST19 with only a single allele, purE, 
harbouring one single-nucleotide polymorphism (SNP) difference. It would be unwise 
to draw any conclusions about recent divergence as studies from this laboratory (Pan 
et al., 2009) showed that a single purE SNP was associated with major genomic 
changes  (loss of an ABC transporter system) associated with PT11 of S. Enteritidis. 
This was a significant differential from S. Enteritidis PT4 and the other ‘virulent’ 
types. It is, however, tempting to suggest that A01 and D01 are likely to be more 
closely related to ST19 than the ST36 type that has 4 allele differences. 
Figure 3-1 shows a phylogenetic tree generated by the ClustalW program from 
the DT104 MLST sequences.  Generally the tree shows that strains A02 and S15 
group furthest away, the next group contains animal strains A01, D02, D11 and D12. 
The rest of the strains show very little difference, although some strains show a higher 
degree of similarity with S22, D03 and D10 being very alike and S01, S02, S04 and 
S24 grouping with the sequenced DT104 strain. Overall, excluding S15 and A02, the 
DT104 strains seem to be very closely related when considering these 7 genes. 
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Table 3-2 The sequence types obtained by the MLST for the 32 test strains. 7 
housekeeping genes were the targets of the MLST primers and their obtained 
sequences were submitted to the MPI MLST database for identification  
  
Strain MLST primer gene target ST 
 aroC dnaN hemD hisD purE sucA thrA  
DT104 10 7 12 9 5 9 2 ST19 
S01 10 7 12 9 5 9 2 ST19 
S02 10 7 12 9 5 9 2 ST19 
S03 10 7 12 9 5 9 2 ST19 
S04 10 7 12 9 5 9 2 ST19 
S05 10 7 12 9 5 9 2 ST19 
S06 10 7 12 9 5 9 2 ST19 
S07 10 7 12 9 5 9 2 ST19 
S13 10 7 12 9 5 9 2 ST19 
S15 18 14 12 9 5 18 21 ST36 
S16 10 7 12 9 5 9 2 ST19 
S19 10 7 12 9 5 9 2 ST19 
S21 10 7 12 9 5 9 2 ST19 
S22 10 7 12 9 5 9 2 ST19 
S24 10 7 12 9 5 9 2 ST19 
S27 10 7 12 9 5 9 2 ST19 
S28 10 7 12 9 5 9 2 ST19 
S29 10 7 12 9 5 9 2 ST19 
S30 10 7 12 9 5 9 2 ST19 
A01 10 7 12 9 71 9 2 UNKNOWN 
A02 18 14 12 9 5 18 21 ST36 
D01 10 7 12 9 5 9 2 ST19 
D02 10 7 12 9 71 9 2 UNKNOWN 
D03 10 7 12 9 5 9 2 ST19 
D04 10 7 12 9 5 9 2 ST19 
D05 10 7 12 9 5 9 2 ST19 
D06 10 7 12 9 5 9 2 ST19 
D07 10 7 12 9 5 9 2 ST19 
D08 10 7 12 9 5 9 2 ST19 
D09 10 7 12 9 5 9 2 ST19 
D10 10 7 12 9 5 9 2 ST19 
D11 10 7 12 9 5 9 2 ST19 
D12 10 7 12 9 5 9 2 ST19 
 
All strains, except S15 shown to have sequence type ST19. Strains S15 and A02 shown to have 
sequence type ST36, strains A01 and D02 shown to have an unknown sequence type. Sequence 
types retrieved from http://web.mpiib-berlin.mpg.de/mlst/dbs/Senterica database 
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Figure 3-1 Phylogenetic tree showing the relatedness of the 32 test strains and the control 
DT104. Created by comparing the sequences of the 7 housekeeping genes of the 
MLST using the ClustalW program 
 
 
 
For bacteria, a mutation frequency (the frequency in which an error in DNA 
replication results in change in an individual base pair) can lie between 10
-7 
and 10
-11
 
per base pair per single round of replication (Madigan et al., 2006). Thus for an 
average gene of around 1000 base pairs, mutations can occur in the range of 10
-4
 to 
10
-8
 per generation. The low values from the MLST data, with A02 and S15 showing 
0.3 substitutions per 100 bases, shows that the variation within these metabolic genes 
is very low. This suggests that those strains which diverge from the main group are 
still evolutionarily closely related. 
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3.2.2 Pulsed field gel electrophoresis (PFGE) 
 
Claudia Lucarelli from the Instituto Superiore di Sanita (ISS) in Italy carried out a 
PFGE assay, using the Xba 1 restriction endonuclease, on the 18 strains from human 
hosts, and has kindly allowed the results to be used. The results are shown in Figure 
3-2. They show the clonal nature of these strains. Each strain had the same PFGE 
profile, XB0061, except for strain S15 which had the profile XB0088. 
Comparing to the SalmGene PFGE database (HPA, http://www.hpa-
bionum.org.uk/bionumerics/salm_gene/) XB0061 shows a common profile with other 
DT104’s, only two other strains show the XB0088 profile and these both are phage 
type U277. This phage type has been isolated in Norway from passerine birds and has 
been shown to fall into the same PFGE group as some DT99 strains (Refsum, 2002). 
 
Discussion 
 
The classification results of the test strain have confirmed that all are S. Typhimurium 
and have the phage type DT104. In addition they have established that the resistance 
profiles associated with the strains before the study are correct. It was therefore 
confidently assumed that the storage of the strains at -80
o
C has not significantly 
affected them and that they will represent the genetic content they had when isolated 
and first stored  
Further classification by MLST and PFGE was carried out to differentiate 
between strains. The use of pulsed-field gel electrophoresis to differentiate between 
bacterial strains has become the international ‘gold standard’ for epidemiology. It 
allows the direct comparison of strains by their banding patterns. The PFGE study 
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carried out on the human DT104 strains showed that apart from one of the strains, 
S15, all showed the same profile.  
The MLST data showed that generally the DT104 strains were clonally 
grouped into ST19, but also revealed two strains with ST36 and two with an unknown 
ST type. The fact that the ST36 group differs by more SNP’s then the unknown group 
may suggest that the later was closer related to the ST19 ‘core’ group. However even 
small changes can have a profound effect on the bacteria as has been shown in S. 
Enteritidis (Pan et al., 2009).  
The use of seven housekeeping genes as the target of the MLST does have 
limitations. Narrowing just to those genes precludes the detection of variation in 
genes that may have more significance to bacterial epidemicity, such as virulence 
genes. The stability of central metabolic genes also reduces the discriminatory power 
of the test when considering very closely related strains. The general clonal nature of 
the strains has been demonstrated by the MLST and PFGE studies. This is suggestive 
that epidemicity with DT104 is due to more discreet changes rather than large scale 
evolutionary development. 
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Figure 3-2 Electrophoresis gel showing PFGE results for human strains S01 – S07, S13, 
S15, S16 and S19, S21, S22, S24 and S27 – S30. All samples show the typical 
DT104 pattern XB0061 profile except S15 (lane 11) which shows the XB0088 
profile.   
 
Results courtesy of C. Lucarelli (ISS).  
1   2    3   4    5    6    7   8    9   10  11 12  13  14 15  16  17 18  19  20  21  22 23  24 
 
Lane Sample Profile 
 
1 Ladder N/A 
2 S01 XB0061 
3 S02 XB0061 
4 S03 XB0061 
5 S04 XB0061 
6 S05 XB0061 
7 Ladder N/A 
8 S06 XB0061 
9 S07 XB0061 
10 S13 XB0061 
11 S15 XB0088 
12 S16 XB0061 
13 Ladder N/A 
14 S19 XB0061 
15 S21 XB0061 
16 S22 XB0061 
17 S24 XB0061 
18 Ladder N/A 
19 S27 XB0061 
20 S28 XB0061 
21 Ladder N/A 
22 S29 XB0061 
23 S30 XB0061 
24 Ladder N/A 
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4 Comparative genetic analysis 
Introduction 
The previous section, described the criteria for strain selection and the initial studies 
that aimed at verifying two key points. First, that the strains used conformed to their 
initial description upon storage and, second, that there was little or no evidence to 
suggest that storage was associated with major genetic changes per se. The data 
generated gave confidence that the strains were as near to their original state on 
storage as could be anticipated: there may of course be some changes such as point 
mutations and possibly rearrangements and deletions.  
To gain an understanding of the possible changes in the panel of strains at the 
whole genome level, it was decided to undertake comparative genomic analysis 
following the methods first described by Anjum et al., (2005). This approach was 
selected as a relatively rapid way of determining the presence or absence of genes 
against a pan-Salmonella array. The outcome of such an approach would be to 
identify any deletions associated with prolonged storage which one could anticipate as 
being possibly random events present in individual strains. Conversely, one might 
anticipate any loss or acquisition associated with the emergence of the epidemic 
strains may be seen as consistent changes in phenotypically related strains. This 
section describes comparative genomic analyses.  
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4.1 CGH Microarray results. 
 
The comparative genomic microarray was carried out as outlined in the methods. The 
data tables are included with the electronic submission. The resultant data was 
analysed with the Genespring software and the results of a Pearson correlation 
clustering is shown in Figure 4-1. This groups the control strains as most divergent, 
separates the antibiotic resistant strains from the sensitive strains and further divides 
the animal resistant strains from the human resistant strains and the sensitive strains 
into three distinct groups. 
1.1.1. Clustering of strains 
 
 
 
 
 
 
 
 
 
 
Animal 
strains A01 
and D06. 
Control 
strain LT2 
Animal 
strains; 
D01, D02, 
D03, D07, 
D08, D09, 
D10, D11 
and D12. 
Resistant 
human 
strains S01, 
S02, S03, 
S04, S05, 
S06, S07, 
S21, S22, 
S24, DT104 
and 
resistant 
animal 
strains D04 
and D05 
Sensitive 
human 
strains S13, 
S16, S19, 
S27, S28, 
S29 and 
S30 
Animal 
strain A02 
and human 
strain S15 
Control 
strains 
SL1344, 
PT4, S. 
Gallinarum, 
S. bongori 
and CT18 
Figure 4-1 Grouping of all test and control strains for all genes on the CGH array using the 
GeneSpring Software. Clustered using Pearson correlation. Presence of genes 
shown by either yellow or red colour, blue indicates absence of the gene in that 
strain  
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4.2 General comparison to sequenced DT104 strain 
 
Comparing the samples to the genes present in the sequenced epidemic DT104 strain 
allows a more detailed study of the genetic differences between strains. This 
comparison suggests splitting the strains into 5 groups; human resistant strains, animal 
resistant strains (1), animal resistant strains (2), sensitive strains (1) and sensitive 
strains (2). See Table 4-1.  
The first identified group contains the human antibiotic resistant strains (S01-
S07, S21, S22 and S24) which have a high similarity (between 99.29% and 99.57%) 
to DT104.  Some genes missing from multiple strains, when compared to the 
sequenced DT104, include; phage related genes (SBG0906, SEN1384 and SYY4610), 
SEN4371 - pefA – fimbrial polypeptide (in strains S05, S06, S07, S21, S22 and S24), 
rsdB – resolvase (in strains S05 and S06), STY0220 – fhuD, ferrichrome-binding 
periplasmic protein precursor (in strains S21 and S22) and STY3961 - ccmC2 
cytochrome related protein (in strains S06 and S07). 
Some genes of note are missing from single strains including; STY0688 – 
dacA, D-alanine carboxypeptidase from strain S06, SBG2553 – ygbF, encoding a 
conserved hypothetical protein from strain S07, and STY4668, a conserved 
hypothetical protein gene associated with SPI7 from strain S21. 
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Table 4-1 Percentage similarity of the 32 test strains to sequenced DT104 and the number 
of missing or addition genes. Data obtained from comparative genomic 
microarray and processed with Microsoft Excel 
 
 
Sample 
No. genes 
missing 
% to DT104 
No. 
Additional 
genes 
% of DT104  
 
S01 17 99.57 28 0.71 
H
u
m
a
n
 R
e
s
is
ta
n
t 
S
tr
a
in
s
 S02 22 99.44 22 0.56 
S03 18 99.55 22 0.56 
S04 26 99.34 3 0.08 
S05 21 99.47 13 0.33 
S06 22 99.44 11 0.28 
S07 25 99.37 6 0.15 
S21 28 99.29 4 0.10 
S22 27 99.32 9 0.23 
S24 25 99.37 22 0.56 
D01 53 98.66 6 0.15 
A
n
im
a
l 
R
e
s
is
ta
n
t 
S
tr
a
in
s
 (
1
) D02 69 98.26 2 0.05 
D03 69 98.26 3 0.08 
D07 39 99.02 2 0.05 
D08 43 98.91 4 0.10 
D09 50 98.74 8 0.20 
D04 57 98.56 40 1.01 
A
n
im
a
l 
R
e
s
is
ta
n
t 
S
tr
a
in
s
 (
2
) 
D05 57 98.56 95 2.40 
D10 63 98.41 56 1.41 
D11 55 98.61 62 1.56 
D12 52 98.69 55 1.39 
S13 93 97.65 2 0.05 
S
e
n
s
it
iv
e
 S
tr
a
in
s
 (
1
) 
S16 59 98.51 7 0.18 
S19 79 98.01 3 0.08 
S27 89 97.75 3 0.08 
S28 80 97.98 5 0.13 
S29 76 98.08 8 0.20 
S30 86 97.83 6 0.15 
A01 140 96.47 27 0.68 
S
e
n
s
it
iv
e
 
S
tr
a
in
s
 (
2
) 
A02 268 93.24 45 1.14 
S15 227 94.27 78 1.97 
D06 160 95.96 50 1.26 
LT2 137 96.54 27 0.68 
C
o
n
tr
o
l 
S
tr
a
in
s
 
SL1344 134 96.62 257 6.48 
PT4 352 91.12 198 5.00 
S.Gal 392 90.11 208 5.25 
S.Bong 1019 74.29 483 12.19 
CT18 504 87.28 812 20.49 
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There are also some additional genes in these strains when compared to the 
sequenced DT104. S01 has 14 genes associated with a S. bongori phage and S02 has 
18 genes associated with the SL1344 plasmid pSLP2. Strains S05 and S06 have the 
HCM1.223 - strA and HCM1. 224 - strB streptomycin resistance genes and the 
HCM1.165c - dhfR – dihydrofolate reductase and HCM1.222 - dihydropteroate 
synthase genes associated with the S. Typhi CT18 HCM1 plasmid. S02 also has the 
same strA gene whilst S07 has a beta-lactamase gene, 
bla
TEM, also identified as 
coming from the same source. Strain S24 has an additional glutaredoxin 
HCM2.0023c. The effect of the resistance genes in strains will be considered below. 
The second group contains 6 animal resistant strains (D01 - D03, D07 - D09) 
with between 98.26% to 99.02% similarity to the sequenced DT104. These strains 
have a number of commonly missing genes including those related to the Fels-1 
prophage (STM0899, STM0900 and STM0918) as well as genes associated with the 
Gifsy-2 prophage (SEN0911 and SEN0912). Two of the strains, D02 and D03, lack 
14 genes between STM2584 and STM2636, which are classified as being from the 
Gifsy-1 phage. They also lack genes associated with an ADP ribosyltransferase 
‘pertussis like’ region STY1041, STY1042, STY1362 and STY1365. All the strains 
show the absence of STY1364 which may also be related to this toxin region. 
Individual strains also show absences of notable genes. Strain D02 lacks 
AF071555_tetR and its homolog AF071555_tetR_DT104 which code for tetracycline 
resistance. D02 also lacks the bla
PSE 
as well which would confer beta lactam 
resistance. Strain D09 lacks STY1825 – gapA, a glyceraldehyde 3-phosphate 
dehydrogenase A and STY3466 – rbfA, a ribosome-binding factor. Strain D03 lacks 
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STY1913 – hyaA, hydrogenase-1 small subunit and STY3961 – ccmC2, heme 
exporter protein C2. 
There are few additional genes identified for these strains. Three strains, D01 -
D03 contain, STY0577 – fdrA. Strain D01 contains additional genes from the S. Typhi 
HCM1 plasmid, HCM1.165c – dhfR a putative dihydrofolate reductase, HCM1.217 – 
a hypothetical protein, HCM1.222 – a dihydropteroate synthase, HCM1.223 – strA, 
streptomycin phosphotransferase and HCM1.224 – strB, streptomycin 
phosphoreductase. 
The third group, Animal Resistant (2), was separated from the first animal 
resistant group because of the higher number of additional genes, between 40 and 95, 
when compared to the sequenced DT104. These strains are missing genes related to 
some mobile genetic elements, from bacteriophage sources such as Fels1 and Gifsy2 
and other prophage regions. Multiple strains are also lacking genes from the SPI7 
region. 
Other genes of note missing from individual strains include: STY1682 – sodC, 
a superoxide dismutase that was missing from strains D10, D11 and D12 and 
STY1913 – hyaA, hydrogenase 1 small subunit and STY1929 – a putative Na+/H+ 
exchanger missing from strains D10 and D11. There was also variation within the 
operon for cobalamin biosynthesis, D10 lacks STY2232 - cbiH, precorrin-3 C17-
methyltransferase and STY2223 - cbiO, a putative cobalt transport ATP-binding 
protein. D12 lacks STY2228 - cbiL, precorrin-2 c20 methyltransferase. Strain D10 
also lacks the genes STY2243 - pduA, putative propanediol utilization protein, 
STY2247 - pduE, diol dehydratase small subunit, STY2290 - gnd, 6-
58 
 
phosphogluconate dehydrogenase and STY2425 - galS, galactose ultrainduction 
factor. 
As noted these strains have more additional genes when compared to the other 
two resistant groups. The majority of these originate from the mobile genetic elements 
present in Enterobacteriaceae including plasmids, bacteriophages and pathogenicity 
islands. Some of these genes are related to antibiotic resistances from the S. Typhi 
plasmids HCM1 and HCM2.  
The fourth group contains the majority of the human derived sensitive strains; 
S13, S16, S19, S27 - S30, from both the pre-epidemic and epidemic period.  These 
have few additional, genes when compared to DT104, but do have between 59 and 93 
genes missing.  Some of these genes are missing for all strains of which 38 represent 
genes from the Salmonella Genomic Island 1 (SGI1) – AF071555 genes, AF261825 
genes, SDT3826 – SDT3864, which confers antibiotic resistance. Two common 
genes, HCM1.162c and HCM1.167, represent a transposase and integrase 
respectively. They also lack genes SEN0911 and SEN0912 associated with Gifsy-2. 
All strains, with the exception of S16, lack SBG0906 a hypothetical phage 
protein. The gene STY1364, which has been associated with a pertussis like toxin, 
was missing from strains S13, S27 - S30.  Other notable gene absences are STY3961 
– ccmC2, a heme exporter protein C2 and STY3964 – ccmF2, a cytochrome C type 
biogenesis protein F2 from strains S13 and S28. Strains S13 and S19 are missing the 
genes STY3006 – sipD, a SPI1 effector protein and STY3725 – thiG, a thiamine 
biosynthesis protein. S13 also lacks two other genes associated with SPI6: STY3007 – 
sipC, encoding an effector protein and spaO, encoding a surface presentation of 
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antigens protein, and also lacks STY4794 – treB, a PTS system trehalose specific 
IIBC compound.  
Some of the missing genes have postulated roles in metabolism. Strains S28 
and S29 are lacking the gene STY2698 – eutG, a putative alchohol dehydrogenase 
involved in ethanolamine utilisation. S27 shows the absence of the D-ribose operon, 
STY3889 – STY3895, including the genes rbsR, operon repressor, rbsK, ribokinase, 
rbsB, D-ribose binding periplasmic protein and rbsC, a high affinity ribose transport 
protein. 
The fifth group consists of four strains which show between 93.24 and 96.47% 
identity to the sequenced DT104. These show a high number of between 140 – 268 
genes missing, and between 27 – 78 additional genes. Common absences include 
SGI1, HCM1.162c and HCM1.167, genes from phage ST104 (SDT0325, SDT0340, 
SDT0343, SDT0356) and prophage 3 (SDT1840 - SDT1843, SDT1865, SDT1868, 
SDT1870).  
Strains A01, A02 and S15 lack prophage 10 (STY1040-1046) as well as genes 
with an association with a pertussis like toxin (SBG0912, SDT2668, STY1362 – 
1365). Absences shared by two strains include the LT2 plasmid (PLST001-PLSTtrb), 
Salmonella pathogenicity island 6 (STY0286-STY0328) and genes from 
pathogenicity islands 7 and 10, for strains S15 and A02, prophage 3 for strains A02, 
D06 and S15 as well as the phage ST104 from strains A01 and A02. 
These strains have a number of additional genes when compared to DT104. 
Common to all four strains was a sequence of 11 genes between STY0566 and 
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STY0577 that have been associated with the utilisation of allantoin as a nitrogen 
source and to glyoxylate metabolism. This will be considered further below. 
A02 and S15 have a significant number of genes for SPI6 from the S. 
Gallinarum gene set, SG0263 – SG0300. S15 shows the presence of the enterobacteria 
phage P2, SBG2807 – BG2845, genes associated with the S. Typhi SPI6 region, 
STY0344 – STY0350 and genes from a S. Typhimurium LT2 phage region, SL2638 – 
SL2643. D06 shows the presence of 4 genes from the HCM1 plasmid, HCM1.108, 
HCM1.270, HCM1.271 and HCM1.281c. 
In total these strains are missing 324 distinct genes when compared to the 
sequenced DT104 strain, of these genes 261 have known association with phages, 
pathogenicity islands, plasmids or the SGI1 region.  Of the 129 additional genes 93 
have the same type of association with mobile or mobilizable elements. 
It should be noted that all the strains in the study lack a series of genes related 
to prophage regions associated with S. Enteritidis; SEN1379, SEN1388, SEN1393 – 
SEN1394 from the prophage SE14 and 6 genes between SEN1936 and SEN1959 
associated with SE20.  These genes were shown to be present in the sequenced 
DT104, but have previously only been reported in S. Enteritidis 
Discussion 
 
The results from the microarray analysis show that genetically the strains generally 
group along resistance rather than any epidemic lines. Resistant strains from the 
epidemic period group together with those resistant strains from the post epidemic 
period. Within the resistance group there was some differentiation between human 
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and animal isolates. Sensitive strains from the pre-epidemic period group with those 
from the post-epidemic period. The major factor which differentiates between strains 
was the presence or absence of the SGI1 chromosomal island which confers antibiotic 
resistance. However some other patterns of difference are observable. 
The majority of variation that exists among the strains lies with genes 
associated with mobile elements. These differences predominantly involve plasmids, 
bacteriophages, prophages or pathogenicity islands. The SGI1 itself, although 
chromosomally located, has been shown to be mobilizable (Doublet et al., 2005a). 
This suggests that the variation within DT104 is probably predominantly driven by 
horizontal gene transfer. Some regions such as that for allantoin and glyoxylate 
utilisation and a ‘pertussis like’ toxin region are interesting. The loss of some genomic 
genes in individual strains, especially those with a possible metabolic cost, may be 
reflecting the selection pressures of cold storage. 
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4.3 Antibiotic resistance 
Introduction 
In the previous section, variability was shown with respect to antibiotic resistance 
genes. It is well established that the resistance genes in the classic penta resistant 
epidemic DT104 types were related to the presence of a specific genomic island 
named SGI-1 that encodes resistance and virulence determinants (Boyd et al., 2001) 
and that some variants have also been described (Doublet et al., 2005a). Here, the aim 
was to describe in more detail the gene content related to SGI-1 present and absent in 
the test panel. 
4.3.1 Variation within SGI-1 
 
The strains with the traditional ACSSuSpT profile, S01 - S03, S05, S07, D01, D03 – 
D05, D07 – D11, show the presence of all the genes from the SGI1 region mirroring 
the sequenced gene cassettes from DT104 (Figure 4-2). These consist of the genes; 
aadA2, qacEΔ1, sulΔ1, floR, tetR, tet(G), blaPSE and sul1. The aadA2 gene codes for 
an aminoglycoside adenyltransferase, which mediates resistance to the 
aminoglycoside streptomycin and the aminocyclitol spectinomycin. Streptomycin 
adenylyltransferase catalyses the transfer of adenyl group from ATP into the 3” and 6’ 
position of the streptomycin molecule, inactivating the enzyme (Jana and Deb, 2005). 
Although the presence of copies of the qacEΔ1 gene would suggest an increased 
resistance to quaternary ammonium compounds, no such increased resistance has 
been seen in E. coli harbouring this gene (Kucken et al., 2000).  
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The floR gene codes for a protein with shows homology to the efflux pump 
encoded by cmlA gene of Pseudomonas aeruginosa, and gives resistance to both 
chloramphenicol and the fluorinated structural analogue of choramphenicol, 
florfenicol (Cloeckaert and Schwarz, 2001; Doublet et al., 2005b). The tetracycline 
resistance gene tet(G)(or tetA) codes for an efflux pump, whilst tetR codes for a 
repressor which controls its expression (McMurry et al., 1980). The 
bla
PSE-1 gene 
codes for a beta-lactamase enzyme that was first characterized in Pseudomonas 
aeruginosa as hydrolysing carbenicillin and a number of other B-lactam antibiotics 
(Matthew and Sykes, 1977). The sul1 gene codes for a dihydropteroate synthase 
which shows a pronounced insensitivity to sulphonamide inhibition (Skold, 2001). In 
combination these genes confer the resistance profile ACSSuSpT. 
 
Variations can be distinguished in the genes making up the SGI1 region. 
While gene AF071555_aadA2 (for streptomycin/spectinomycin adenyltransferase) 
was absent from DT104 strains S15 and A02 as well as the control strains S. 
Gallinarum, S. Typhi CT18, S. bongori, it was present in the rest of the strains. The 
homologue for AF071555_aadA2, SDT3850, was only present for those DT104 
strains that have antibiotic resistant profiles.  Variant resistance profiles were also 
identified by the microarray data. Strains D02, D12, S21, S22 and S24 which have the 
profile SSu showed only the presence of the resistance genes aadA2, qacEΔ1, sulΔ1 
and sul1, conferring resistance to streptomycin and sulphonamides. The S04 strain 
showed similar variation with aadA2, qacEΔ1, sulΔ1, floR and sul1. These genetic 
variations were mirrored by variation in the resistance profiles confirmed by the 
antibacterial MIC. 
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Figure 4-2 Pictorial representation of the Salmonella Genomic Island 1. Genes for 
antibiotic resistance are represented by the hashed boxes 
 
 
4.3.2 Other antibiotic resistances 
 
Other genes, dhfR, sul-2, strA, strB and 
bla
TEM, which confer antibiotic resistances, 
were detected by the microarray results in strains S05, S06 and D01.  These were 
identified from genes on the array that were from the S. Typhi CT18 HCM1 plasmid. 
This is an incHI1 antimicrobial resistance plasmid first isolated from cases of 
multidrug resistant typhoid fever in Vietnam in 1993 (Wain et al., 2003), that contains 
antibiotic resistances on gene cassettes as well as genes for mercury resistance (Phan 
et al., 2009). Hybridisation with these specific gene probes does not necessarily imply 
that the presence of the S. Typhi CT18 HCM1 plasmid but rather that similar 
resistance genes were present. 
Picture adapted from (Mulvey et al., 2006)  
 
thdF int xis rep S004 S005 S006 S007 S008 S009 S010 trhG 
trhG trhH S013 S014 S015 S016 -18 S019 S020 S021 -22 S023 
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floR tetR tet(G) orf1 orf2 groEL/int1 blaPSE-1 qacEΔ1 sul1 
orf6 tnpA S044 
5’ 
3’
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 The dhfR gene encodes a dihydrofolate reductase and as such could provide 
the resistance to trimethoprim present in strain S05. Trimethoprim acts as a 
dihydrofolate reductase inhibitor and therefore interferes with purine and thymidylate 
biosynthesis and ultimately cell division and proliferation. Sul-2 encodes a 
dihydropteroate synthase providing resistance to sulphonamides. Two genes strA and 
strB code for enzymes for resistance to aminoglycoside antibiotics such as 
streptomycin. Also detected was a 
bla
TEM coding for a beta-lactamase and conferring 
resistance to beta-lactam antibiotic penicillins including ampicillin. Both 
bla
TEM and 
sul-2 are usually located on plasmids (Skold, 2001). 
Discussion 
 
The CGH microarray data confirms the presence of the genes that make up the 
classical SGI1 in the 14 strains with the penta-resistant profile. Those strains with 
variant profiles that showed fewer resistances also showed variation with the loss of 
some genes from this region. One limitation of the comparative genomics technique is 
that novel additions and re-arrangements within the SGI1 would not be detected. To 
interrogate possible changes within this region more comprehensively a sequencing 
based technique would have to be used. However from the microarray data it is 
reasonable to assign known variant structures to some strains.  
Since the composition of the classical Salmonella Typhimurium DT104 SGI1 
has been described (Boyd et al., 2001) other examples with different resistance 
profiles have been identified.  Variants SGI-A to SGI-O have been described in 
Typhimurium and also in Proteus mirabilis, and variant genomic island with a 
different lineage, termed SGI2 has also been described (Boyd, 2008; Levings, 2008; 
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Mulvey et al., 2006). The genetic results and the resistance profiles ascertained in the 
study suggest that strains D02, S21, S22 and S24 have the variant SGI1-C (Mulvey et 
al., 2006). 
The presence of the resistance genes 
bla
TEM, strA, strB and sul2 in strains S05, 
S06 and D01 is suggestive of a unique resistance determinant region. These genes 
have recently been associated with a clonal group of S. Typhimurium and its 
monophasic variant Salmonella enterica subsp. enterica serovar 4,[5],12:i:- that 
emerged during the 2000’s. These strains display the resistance profile ASSuT and the 
resistance genes have been shown to occur in a separate and distinct chromosomally 
encoded region when compared to SGI1 (Lucarelli et al., 2010).  The presence of a 
subset of these HCM1 genes, but not the whole plasmid, suggests that these strains 
may contain this newly identified region or another plasmid or plasmids with these 
genes. 
4.4 Genomic differences 
 
Introduction 
The microarray data has confirmed the resistance profiles and also uncovered 
variation within genes related to antibiotic resistance. The acquisition of antibiotic 
resistance by DT104 is thought to have coincided with the emergence of the epidemic.  
However other differences have been uncovered by the microarray study that could 
also affect the relative fitness of the strains and therefore may have an impact on their 
epidemicity.  
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4.4.1 Allantoin and Glyoxylate 
 
S. Typhimurium LT2 contains a region of 11 genes, STY0566-STY0577, which was 
absent from the sequenced DT104. The list of these genes and their predicted 
functions are listed in Table 4-2. 
Table 4-2 List of genes STY0566-STY0577 present in S. Typhimurium LT2 but absent 
from the sequenced DT104 genome. These genes are involved in glyoxylate and 
allantoin utilisation 
 
Gene I.D. Function  
 
STY0566 hyi, hydroxypyruvate isomerase, glyoxylate induced protein 
STY0567 glxR, 2-hydroxy-2-oxopropionate reductase 
STY0568 Probable metabolite transport protein 
STY0569 ybbW, Putative allantoin permease 
STY0571 allB, putative allantoinase 
STY0572 Putative permease 
STY0573 glxK, glycerate kinase 
STY0574 Conserved hypothetical protein 
STY0575 allC, allantoate amidohydrolase 
STY0576 allD, ureidoglycolate dehydrogenase 
STY0577 fdrA, involved in protein transport 
 
STY0566 – STY0577, are absent from the majority of resistant and sensitive 
test strains but are found in human sensitive strain S15 and animal sensitive strains 
A01, A02 and D06, as well the control strains LT2, SL1344, PT4, S. Gallinarum and 
CT18. This region has been previously identified as being present in some strains of 
DT104 that are sensitive, and it has been hypothesised that the loss of this region pre-
dates the acquisition of SGI1 in resistant strains (Matiasovicova et al., 2007).  
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4.4.2 Ribose 
 
Of all the strains tested by microarray only human sensitive strain S27 shows the 
absence of the D-ribose operon; STY3889, STY3891, STY3892, STY3894 – 
STY3895. The gene identifications are listed in Table 4-3. 
Table 4-3 List of genes STY3889-STY3895 present in S. Typhimurium strains including 
DT104.. These genes are associated with the ribose operon. They are missing 
from human sensitive strain S27 
 
Gene I.D. Function  
 
STY3889 yieO,putative transmembraneefflux protein 
STY3891 rbsR, ribose operon repressor 
STY3892 rbsK, ribokinase 
STY3894 rbsB, D-ribose-binding periplasmic protein 
STY3895 rbsC, high affinity ribose transport protein 
  
  
  
4.4.3 ‘Pertussis like’ region 
Another area of interest that arises from the study is the presence or absence of a 
series of genes coding for a predicted pertussis like toxin similar to the one from 
Bordetella pertussis. This region has been characterised in DT104 as containing an 
ADP-ribosyltransferase toxin homologue (artA, artB) that is flanked by prophage like 
sequences suggesting acquisition by phage mediated recombination (Saitoh, 2005).  
Figure 4-3 shows variation with genes associated with the pertussis-like toxin 
region. All the animal strains, two of the sensitive human strains S13 and S15, as well 
as the pre-epidemic sensitive strains S27-S30 lack the gene STY1364 which encodes 
artB, one part of the artA/B toxin gene pair. Sensitive strains A01, A02, D02, D03 and 
S15 also lack genes surrounding this gene, STY1362 and STY1365. 
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Other gene homologues of the 7 open reading frames identified by Saitoh et al 
in the DT104 ADP-ribosyltransferase region show the same pattern of presence. Orf5 
- STY1040, a holin, and orf6 - STY1041, a prophage membrane protein are missing 
from A01, A02, D02, D03 and S15. The same pattern exists for gene SBG0912 which 
shows a 94% identity to the pertussis gene artA/B and its flanking region. 
Figure 4-3 Presence of genes STY1362, STY1364 and STY1365 associated with a ‘pertussis 
like’ toxin in the 32 test strains from the comparative genomic microarray   
 
 
4.4.4 PCR for artA/B presence in strains 
 
Using the artA/B toxin region identified in DT104 (Saitoh, 2005) and the 
available sequence of DT104 (Dougan), PCR primers were designed to test the 
presence artA/B genes. A PCR was carried out for all strains in the study.  
 
Figure 4-4 shows the results for the artA/B bridging region. The absence of the 
region was confirmed in strains S15, D02, D03, A01, A02 and the negative control 
strain LT2. This supports the results from the microarray (Figure 4-3 above) which 
shows that these strains lack all three of the genes; STY1362, 1364 and 1365.  
Sequencing of the artA/B region was carried out on the 10 strains; S01, S04, 
S05, S13, S21, S24, S27, D01, D10 and the sequenced DT104. These were chosen 
because they showed either total or partial presence of the region from the CGH                                            
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microarray results (Figure 4-3 above). The completed sequences were processed with 
DNASTAR Lasergene SeqMan and MegAlign. Figure 4-5 shows the alignment of the 
strains from a screen grab from the MegAlign software. 
 
Figure 4-4 Electrophoresis 1% agarose gel with ethidium bromide staining. PCR product 
for artA/B bridging regions for all 32 test strains run on gel for 1hr with a 1kb 
ladder. Expected product size 1340b 
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Figure 4-5 Alignment of a subset of 10 of the test strains using their obtained sequences in 
the MegAlign software 
 
  
The ClustalW phylogenetic tree grouping of the strains is shown in Figure 4-6. 
The strain that diverges most from the others was human sensitive strain S13 from the 
later period. The next most divergent are human resistant strains S04 and S05 from 
the epidemic period. S21 a later resistant strain, also shows some divergence. The rest 
of the strains group closer together. The sequencing data showed that there was 
variation within the artA/B region. The greatest variation was with S13, which has 
shown variance from the CGH microarray data. Other strains in which variation was 
predicted, D01, D10, S27, in fact showed little difference from strains that showed the 
presence of the whole region. 
Figure 4-6 ClustalW phylogenetic tree of sequenced artA/B region from the MegAlign 
software, showing variation in the number of nucleotide substitutions and the 
relationship between the strains variation. 
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4.4.5 pdu/cob regulon 
 
Animal strain D10 shows the absence of some genes from a region associated with the 
biosynthesis of adenosyl-cobalamin (vitamin B12) and with the catabolism of 1,2-
propanediol. The cob operon for B12 synthesis consists of 25 genes and is split into 
three groups, each encoding enzymes for a distinct part of the pathway (Roth et al., 
1993). The missing genes cbiO, a putative cobalt transport ATP binding protein and 
cbiH, precorrin-3 C17-methyltransferase, come from group I that bring about the 
synthesis of cobinamide. The synthesis of only a few enzymes in E. coli are B12 
dependent including ethanolamine deaminase and propanediol dehydratase (Roof and 
Roth, 1989). 
Adjacent to the cob operon is the pdu operon, which controls the breakdown 
of 1,2-propanediol to propionaldehyde. This can be used as hydrogen sink when 
converted to propanol and excreted or can be used as a carbon source converting to 
pyruvate via propionyl-coenzyme A. These two operons are induced by propanediol, 
via the activator pocR, and are under positive control of the global regulatory proteins 
Crp and ArcA (Chen et al., 1994).  Strain D10 was missing the genes pduA, 
propanediol utilization protein and pduE, a diol dehydratase small subunit. 
4.4.6 Mobile elements 
 
4.4.6.1 Plasmids 
 
The 93 kb virulence plasmid from LT2, pSLT, is included on the CGH microarray 
and was shown to be present in all strains except animal sensitive strain A02 and 
human sensitive strain S15. Plasmid pSLT and the virulence plasmids from other 
73 
 
serovars including SL1344 have been shown to be self-transmissible, although in the 
latter case at a much lower frequency (Ahmer et al., 1999; Garcia-Quintanilla and 
Casadesus, 2011).  The lack of this region in these strains is interesting, but has not 
been confirmed by plasmid extraction, and this would be a target for further work. 
 In addition to pSLT human resistant strain S02 possesses 18 genes of the 103 
genes representing the S. Typhimurium SL1344 plasmid SLP2. This may be 
indicative of a distinctive plasmid or a truncated/chimeric derivative in this strain. 
Other plasmids in S. Typhimurium serovars have been shown to carry integron-borne 
gene cassettes and both virulence determinants and antibiotic drug resistance genes 
(Guerra et al., 2002). The presence of unique plasmids may therefore have 
implications for epidemicity. 
4.4.6.2 Fels-1 phage 
 
Figure 4-7 shows the presence and absence of genes associated with the Fels-1 phage 
(STM0893-0929). The strains with animal origin D01-D12 show the general absence 
of these genes. S13, a sensitive human strain, also shows a greater variation in this 
region when compared to the other human strains. 
Figure 4-7 Presence or absence of genes STM0893-STM0929 associated with the Fels-1 
phage in the 32 test strains from the comparative genomic microarray   
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4.4.6.3 Gifsy-1 phage 
 
Animal resistant strains D02 and D03 have been shown to be negative for Gifsy-1. 
The lambdoid prophage Gifsy-1 from S. Typhimurium has been shown to effect 
virulence in strains that lack the Gifsy-2 prophage region. Curing S. Typhimurium of 
Gifsy-1 and Gifsy-2 reduces the virulence of the bacterium in mouse models 
(Figueroa-Bossi and Bossi, 1999).  
Discussion 
The genetic data from the microarray has shown some differences between strains that 
may have implications for both strain fitness and virulence. The presence of genes 
involved in allantoin and glyoxylate utilisation may have an important impact on the 
bacterial metabolism and their loss in the ‘epidemic’ resistant strains may have 
significant implications for epidemicity. The loss of this region has been reported to 
have pre-dated the acquisition of the antibiotic resistant region SGI1 (Matiasovicova 
et al., 2007). It may therefore play an important role in the evolution of the epidemic 
strain. The loss of the ribose operon from one strain and the pdu/cob operon from 
another may have significance. 
The absence of the region associated with a ‘pertussis’ like toxin from some 
sensitive strains was also marked. This toxin region has been reported to be inactive 
in DT104 because of at least one frame shift (Hermans, 2005a; Parkhill et al., 2001). 
However a recent study has shown that the genes in this region can be transcribed in 
DT104 and produce an ADP ribosyltransferase (Uchida, 2009). Therefore the 
presence of this region in DT104 may have a more important role in virulence and 
epidemicity than first thought. 
75 
 
The comparative genomic hybridisation array has revealed genetic differences 
between the strains. The drawbacks of the technique have also become apparent; it is 
unable to identify novel genes, it would not identify mutations within genes or 
rearrangements within regions. The results involving mobile elements suggest that 
cross hybridisation with common phages may also confuse the overall picture.  
Overarching these problems is the fact that the presence of a gene does not 
automatically mean it is actively transcribed. For that reason, and to confirm the 
genetic results, a comprehensive study, using the Biolog phenotyping microarray, was 
carried out.  
4.5 Optical Mapping 
Introduction 
 
Another question arising from the studies above and not answerable by CGH alone is 
the possibility of genomic rearrangements. Whilst CGH approaches can give sound 
data on the presence or absence of genes, it is not able to provide any relational or 
spatial data. As described above, it has been possible to postulate that certain gene 
combinations are likely to reflect certain gene relational structures such as in the SGI1 
and its variants. In addition the presence of phage related integron and excision genes, 
but not the whole phage related to them on the array, suggests that novel phages may 
be present.  However, without definitive data from sequence approaches these can 
only be speculative deductions and therefore prone to drawing inaccurate conclusions. 
During the course of this study, the opportunity to utilise a new system of Optical 
Genetic Mapping to establish the physical maps of the various genomes became 
available. Here, a subset of 9 of the DT104 strains, along with field isolates from the 
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serovars S. Enteritidis (1 strain), S. Newport (7 strains) and S. Dublin (3 strains), were 
investigated with a novel technology, optical genetic mapping. The data for all three 
serotypes have now been published  (Saunders et al., 2010). The approach generates a 
physical map of the whole bacterial chromosome for the comparison of strains of 
Salmonella to each other and the available sequenced strains.  
This method has the capacity to combine greater resolution, positional 
information and the identification of novel insertions to an extent that is lacking from 
techniques such as PFGE. In brief, specific restriction endonucleases cut the DNA of 
a bacterium that has been stretched out and immobilised on a derivatized glass slide. 
The restriction fragments are fluorescently labelled in situ, and then are visualised and 
photographed. The mass of each fragment is determined by the intensity and partial 
genome maps are developed. These are assembled by overlapping segments into a 
genome optical map using alignment software. Optical maps for the 20 Salmonella 
serovars were prepared by OpGen, Gaithersburg, MD, USA following the method 
presented in Zhou et al. (2004) (Zhou, 2004) 
4.5.1 Genome alignment relationships. 
 
The OpGen MapSolver software was used to create an unweighted pair group 
method with arithmetic mean (UPGMA) to create a phylogenetic tree of the optical 
maps from the available in-silco Salmonella sequences and those generated from the 
S. Typhimurium and other test strains ( Figure 4-8).  The clustering correctly grouped 
the test strains with their respective ‘control’ sequenced strains. The 9 S. 
Typhimurium test strains showed little variation with a 0.8% difference within the 
group. The exception to this was strain S15 which grouped closer to the LT2 control 
strain. The sequenced S. Dublin and 3 S. Dublin test strains showed the least variation, 
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with 0.3% difference within the group. The 7 S. Newport test strains generally 
clustered into two groups which will be briefly discussed below. The S. Enteritidis 
test phage type 11 strain P3854860  clustered closer to the S. Dublin strains than to 
the control S. Enteritidis phage type 4 strain P125109, which was closer to the 
sequenced Gallinarum strain with a 1.8% difference. 
The in-silico optical maps of the sequenced S. Typhimurium LT2 and 
multidrug resistant DT104 were compared (Figure 4-9). The regions identified as 
mobile elements and their genomic coordinates for LT2 by Hermans et al (Hermans, 
2005a) and for DT104 by Cooke et al (Cooke et al., 2007), are highlighted.  The 
variation between the strains was predominantly in these regions associated with 
mobile elements, notably prophages. S. Typhimurium LT2 contains the regions of the 
bacteriophages Fels-1 and Fels-2 that are absent from DT104. Fels-1 has been shown 
to contain the genes sodCIII (superoxide dismutase), nanH (neuraminidase) and grvA. 
DT104 contains prophage 1 (ST104), prophage 3, prophage 4 and the Salmonella 
Genomic Island 1 (SGI1) that are absent from the LT2 strain. This later region 
contains the genes that confer antibiotic resistance to DT104 strains (Boyd et al., 
2001). Both strains show the presence of Gifsy-1 and Gifsy-2, two lambda-like 
phages that have been associated with virulence (Brüssow, 2004). 
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Figure 4-8 Unweighted pair group method with arithmetic mean (UPGMA) phylogenetic 
tree of the optical maps from the available in-silco Salmonella sequences and 
those generated from the S. Typhimurium and other test strains. Showing 
percentage difference between strains 
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4.5.2 Variations within the S. Typhimurium test strains. 
 
Nine of the test strains were analysed with this technique, S01, S04, S06, S15, S16, 
S221, S27, D01 and D07. The upper part of Figure 4-10 shows regions of variation 
between the S. Typhimurium strains S21 and the sequenced DT104. A 40kb insert 
downstream from prophage 5 was identified, that was absent from the sequenced 
strain. This insert was located upstream of genes related to purine metabolism (purM 
and purN) and ppk (polyphosphate kinase) and downstream of guaB (inositol-5-
monophosphate dehydrogenase).   
Strains S21 (Figure 4-10) and S04 (not shown) are antibiotic resistant but have 
different profiles from the penta-resistant profile of the sequenced strain. These 
differences in resistance profile were visible by optical mapping, with partial deletions 
in the region of SGI-1 in the test strains, between bases 4,115,969 and 4,124,741 for 
strain S21 and between bases 4,112,582 and 4,122,042 for strain S04. This region 
encompasses the second ‘resistance cassette’ of the genomic island including, for S21, 
the genes tet(G), groE1/int1, 
bla
pse-1, qacEΔ1, sul1 and tnpA, and for S04 the genes 
floR, tetR, tet(G), groE1/int1, 
bla
pse-1 and qacEΔ1 (Boyd et al., 2001).  
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Figure 4-9 Comparison of the optical maps of control LT2 and DT104 strains. Yellow 
blocks represent the identified phage and prophage regions of LT2 and DT104. 
The green region represents the Salmonella Genomic Island 1. The genomic 
location of the regions is listed in the table below 
 
  
Typhimurium, LT2
Typhimurium, DT104
Typhimurium, LT2
Typhimurium, DT104
Prophage 1 (ST104)
Fels-1    Gifsy-2
Gifsy-2 Prophage 3   Prophage 4
Gifsy-1   Fels-2
Gifsy-1 SGI-1
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Figure 4-10 Comparison of the optical maps of the control DT104 strain and 3 DT104 test 
strains. On top between control DT104 and post epidemic human strain S21. 
Below between control DT104 strain pre epidemic human strain S27 and post 
epidemic human strain S16. Prophage 5 from DT104 is highlighted in yellow 
and the Salmonella Genomic Island 1 is highlighted in green 
 
 
The lower part of Figure 4-10 shows the total absence of the SGI-1 region 
from two strains, S16 and S27, both of which were sensitive to the panel of antibiotics 
that the sequenced strain was resistant to.  
Aside from the presence, absence or variation within SGI-1, the insertion in 
S21 and the atypical strain S15, the optical mapping technique revealed the largely 
clonal nature of strains from the phage-type DT104.  
 
 
 
 
82 
 
Discussion 
 
The optical mapping technique demonstrated the ability to identify variation between 
strains. The comparison between the sequenced DT104 and the sequenced LT2 
demonstrates that the variation lies largely with the phage and prophage regions and 
the SGI1. The other region shown, between prophage 1 (ST104) and Fels-1 is the 
allantoin / glyoxylate region also identified by the CGH study.  The variation 
observed in the SGI1 regions of the optical maps for strains S04 and S21 confirms 
that from the CGH and the antimicrobial MIC. 
Novel insertions were observed with the optical maps, a 40kb insert was 
identified in strain S21, between the genes ppk and guaB. The gene ppk codes for a 
polyphosphate kinase and the disruption of its transcription may have implications for 
the fitness of the strain. This information and the results from the microarray suggest 
the ubiquitous nature of phages within Salmonella Typhimurium, and infer a role for 
them in the evolution of DT104. The possible cost of phage acquisition on the fitness 
of the affected strain can also be investigated through the Biolog phenotyping study. 
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5 Phenotyping microarray results 
Introduction 
The previous sections have focused largely on the genetic differences between the test 
strains that span the DT104 epidemic and other reference strains, notably S. 
Typhimurium LT2, a sequenced strain. These studies have shown a number of 
differences that are likely to impact on the phenotype of the organism: the presence of 
allantoin and glyoxylate utilisation genes, the absence of a ribose operon for one 
strain and the pdu/cob operon for another. There is also the possibility that a novel 
insertion, which may be a phage, in S21 may have affected the transcription of 
phosphate kinase. However the methods have their limitations and for CGH, the key 
limitation is the statistical algorithms to establish cut-offs for gene presence and 
absence. Whilst being confident that the analyses are sound, it is important to verify 
any gene differences observed by CGH by alternative means.  
The obvious test for those gene changes from the LT2 backbone that impact 
on phenotype is to verify the phenotype. To do this a study using the Biolog 
phenotyping microarray was used. This works by measuring the respiratory 
conversion of a tetrazolium dye by the bacteria in the presence of sole carbon, 
nitrogen, phosphorus or sulphur compounds in a minimal medium. The technique 
therefore allows the screening of the strains against a panel of compounds that 
represent those that may be available for central metabolism, and as such can give a 
measure of the fitness of the strain and a reflection of its genetic content.  
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5.1 Novel phenotyping approach using Biolog Phenotypic MicroArray™ 
 
The overall results for the phenotypic array carried out for the test strains are 
presented in Appendix 2 of the electronic submission. For this the cut-off for positive 
respiration was an OD of 150 at the 24 hour point. Statistical grouping of the 
metabolic results via Pearson correlation did not group them by date of isolation, host 
species or resistance profile.  
As a baseline comparison the sequenced DT104 strain uses 82 of the 95 
carbon compounds on PM1, 8 of the 95 carbon compounds on PM2a, 31 of the 95 
nitrogen compounds on PM3, 34 of the 59 phosphorus compounds and 10 of the 35 
sulphur compounds on PM4a.  A comparison between test strain compound utilisation 
and the sequenced DT104 at the 24 hour point is shown in Table 5-1. Overall the 
strains are between 71.61% and 93.75% similar in their metabolic profile to the 
sequenced DT104. With the removal of data from PM2a (as will be discussed below), 
the similarity does increase slightly from 73.96% - 94.44%. This can be compared 
with the range of genetic similarity, 99.57% - 94.27%, as shown by the CGH 
microarray 
The data shows some broad patterns. Human strains use an average of 48.3 
extra compounds compared to 13.4 in the animal strains. The variations within these 
numbers is notable, S15 using 109 compounds, S16 using 85 and S07 using 80. At the 
other end of the scale strain S21 uses only 10 extra compounds and strain S22 uses 11 
extra. 
For compounds not used, when compared to the sequenced DT104, animal 
derived strains show less utilisation than human strains. Human strains have a median 
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value of 6 compounds not used and average of 17.5, compared to 13 and 23.8 
respectively for the animal strains. Some individual strains do show higher non-usage 
for example S21 not utilizing 68 compounds, S22 not utilizing 67, D03 not utilizing 
53 and D06 not utilizing 61. 
 
Table 5-1 Comparison of compound usage between test strains and sequenced DT104  
  strain from the Biolog phenotypic microarray plates ant the 24hr point. Data 
  presented as the percentage of similarity. The second percentage column shows 
  the same data but with the results from plate PM2a excluded.   
 
 
Strain 
Compounds in 
common with 
DT104 
Additional 
compounds 
Compounds 
not used 
% 
similarity 
to DT104 
% 
similarity,  
- PM2a  
S01 313 62 9 81.51 90.63 
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 d
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S02 308 70 6 80.21 91.32 
S03 320 58 6 83.33 94.44 
S04 325 52 7 84.64 86.11 
S05 319 58 7 83.07 93.40 
S06 333 46 5 86.72 88.19 
S07 302 80 2 78.65 86.81 
S13 316 62 6 82.29 93.06 
S15 275 109 0 71.61 86.46 
S16 294 85 5 76.56 92.36 
S19 352 28 4 91.67 90.97 
S21 306 10 68 79.69 73.96 
S22 306 11 67 79.69 73.96 
S24 349 20 15 90.89 89.93 
S27 341 39 4 88.80 87.85 
S28 348 31 5 90.63 89.58 
S29 353 21 10 91.93 90.28 
S30 343 37 4 89.32 87.85 
A01 338 9 37 88.02 85.07 
A
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A02 344 5 35 89.58 86.46 
D01 354 17 13 92.19 90.28 
D02 352 24 8 91.67 89.58 
D03 328 3 53 85.42 81.25 
D04 358 5 21 93.23 91.67 
D05 346 11 27 90.10 88.54 
D06 321 2 61 83.59 78.82 
D07 343 28 13 89.32 87.15 
D08 352 18 14 91.67 89.24 
D09 355 19 10 92.45 90.63 
D10 349 28 7 90.89 88.19 
D11 360 14 10 93.75 92.36 
D12 356 4 24 92.71 91.32 
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5.2 Carbon source plate PM1 
 
On PM1 the sequenced DT104 was able to use 82 of the 95 carbon compounds. 
Human strains could on average use more compounds than strains of an animal 
origin, at 83 compared to 73. Animal strains A01 (58 compounds) and D06 (66 
compounds) use the fewest carbon sources, while strains S15 (93 compounds) and 
S16 (92 compounds) use the most. Compounds that show different utilisation patterns 
are listed and specific examples are highlighted below. 
5.2.1 m-Tartaric acid and Glyoxylic acid 
 
Table 5-2 shows the positive utilisation of two compounds, m-Tartaric acid and 
Glyoxylic acid. Figure 5-1 shows the metabolism of Glyoxylic acid and Figure 5-2 
that of m-Tartaric-acid. These graphs demonstrate the ability of post epidemic animal 
strain A02 and post epidemic human strains S15 and S16 to metabolise glyoxylate 
and post epidemic animal strain strains A02 and D06 and post epidemic human strain 
S15 to metabolise m-Tartaric acid.  
 
  Table 5-2 Pattern of m-Tartaric acid and Glyoxylic acid utilisation from the Biolog 
phentotypic microarray plates. 
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S16 
S15 
A02 
S15 
A02 
D06 
Figure 5-2 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period  in the presence of the sole carbon source 
m-Tartaric acid 
  
Figure 5-1 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period  in the presence of the sole carbon source 
Glyoxylic acid. 
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The carbon compounds m-Tartaric acid and glyoxylate identified from above 
were further investigated via a growth rate assay to confirm the phenotype and 
directly connect increased respiration to growth. Figure 5-3 shows the results for the 
strains grown in minimal medium with 0.4% Glyoxylic acid, pH controlled. The 
control strains LT2 and S. Gallinarum and the test strain S15 all showed the ability to 
grow in the minimal medium with 0.4% glyoxylate w/v. No growth was seen with test 
strains S01, S04, S07, S21, S24, S27 and S30. Also no growth was achieved with the 
same growth media substituting glyoxylate with m-Tartaric acid with any of the test 
strains. 
5.2.2 Tricarballylic acid 
 
The utilisation pattern for the sole carbon source Tricarballylic acid is shown in 
Figure 5-4. Strain S16 was shown to have an extended lag phase and less respiration 
than the other strains. 
 
5.2.1 N-Acetyl-D-Glucosamine 
 
Figure 5-5 shows the pattern of growth with N-Acetyl-D-Glucosamine as a sole 
carbon source. The compound clearly differentiates human derived stains from animal 
derived ones. The upper group contains the human strains S01-S07, S13, S15-S16, 
S19, S21-S22, S24 and S27-S30 while the lower group contains the animal strains 
A01-A02 and D01-D12.  A similar pattern, although not as clearly defined, exists for 
the compound Acetoacetic acid. 
 
89 
 
Figure 5-3 Growth of strains in minimal medium with 0.4% glyoxylate w/v. Increased 
growth, shown by increase in optical density at 600nm against time. LT2, S. 
Gallinarum and S15 show log. growth at around 48 hours  
 
 
 
 
 
S16 
Figure 5-4 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period  in the presence of the sole carbon source 
Tricarballylic acid  
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D06 
Human 
strains 
Animal 
strains 
A01 
Figure 5-5 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period  in the presence of the sole carbon 
source N-Acetyl-D-Glucosamine 
Figure 5-6 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period  in the presence of the sole carbon 
source D-Saccharic acid 
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5.2.2 D-Saccharic acid 
 
Figure 5-6 shows that two animal strains A01 and D06 showed little or no respiration 
when D-Saccharic acid was the sole carbon source.  
5.2.3 D-Cellobiose 
 
Some human strains demonstrated comparatively better ability to use D-Cellobiose as 
a sole carbon source. This group, which includes strains S27, S28, S22, S21, S19, S16 
and S30, showed increased respiration when compared to the other human and animal 
strains. One caveat is that the replicates for these strains showed a degree of 
divergence, although they did show a collective positive response. It is possible that 
this divergence may be due to a slightly different concentration of the compound 
within the original plates. 
5.2.4 Tyramine 
 
Figure 5-7 shows that one animal derived strain, D08, showed little or no respiration 
when grown in minimal media containing the compound Tyramine as a sole carbon 
source. 
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D08 
Figure 5-7 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period  in the presence of the sole carbon source 
Tyramine 
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5.3 Carbon source plate PM2a 
 
On PM2a the sequenced DT104 strain shows the ability to use 8 of the 95 carbon 
compounds (AbuOun et al., 2009).  The first ten strains tested with this plate, (S01-
S07, S13, S15 and S16) showed positive results from between 25 to 78 compounds, 
whilst the remaining 22 strains showed positive reactions with 5 to 16 compounds. 
Re-testing with two strains from the first group, S04 (12 compounds) and S15 (10 
compounds), suggested that the largely positive reaction from that group may be an 
experimental anomaly. Thus the results from PM2a should be treated with a degree of 
caution in relation to the strains in the first group. For that reason, fewer examples 
have been drawn from this data, and the ones that have been chosen are, at least in 
part, confirmed by the retested strains. 
5.3.1 D-Lactic acid methyl ester 
 
Figure 5-8 shows that animal strains A01 and D04 - D12 had no ability to use D-
Lactic acid methyl ester as a sole carbon source. The retested strains S04 and S15 also 
fit this profile, both showing positive responses.  
5.3.2 L-Sorbose 
 
Strain S16 showed a greater ability to utilise L-Sorbose than the other strains (Figure 
5-9). Other strains that responded did so in only one of their duplicates, and should be 
considered suspect. The work of Woodward and Charles (Woodward and Charles, 
1982) showed that L-Sorbose was used variably amongst the Enterobacteriaceae and 
that some strains were fully capable, others mutable and other incapable. It would 
appear the same is true within this group of test strains.   
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S16 
A01, D04-D12 
Figure 5-8 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period  in the presence of the sole carbon source D-
Lactic acid methyl ester 
  
Figure 5-9 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period  in the presence of the sole carbon source L-
Sorbose 
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5.4 Nitrogen source plate PM3b 
 
Plate 3b contains 95 different nitrogen compounds and uses succinate as a carbon 
source. The sequenced DT104 strain is able to utilise 31 compounds as a sole nitrogen 
compound (AbuOun et al., 2009). Two human strains, S21 and S22, showed a marked 
reduction in the number of usable nitrogen compounds compared to the others. This 
suggests a fundamental problem with the uptake or metabolism of sole nitrogen 
sources. These two strains were limited to metabolism of uric acid and four dipeptide 
pairs; ala-asp, ala-gln, gly-met and met-ala. The other test strains were positive for 
between 23 and 45 compounds, with human strains having a slightly higher average 
than animal strains at 39 compared to 31. 
5.4.1 Ammonia 
 
Three human strains (S04, S07 and S27) showed the ability to utilise ammonia as a 
sole nitrogen source (Figure 5-10). The sequenced DT104 strain showed no growth 
when ammonia is the sole nitrogen source, so the growth of these three strains is 
notable. Some of the other strains began to reduce the dye towards the end of the time 
period, perhaps suggesting that eventually strains begin to adapt to the sub-optimal 
conditions. 
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S27 
S07 
Figure 5-10 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period in the presence of the sole nitrogen 
source ammonia 
Figure 5-11 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period in the presence of the sole nitrogen 
source N-Phthaloyl-L-Glutamic acid 
S07 
S04 
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5.4.2 N-Phthaloyl-L-Glutamic acid 
 
With the nitrogen compound N-Phthaloyl-L-Glutamic Acid strain S07 was the 
first to show a significant respiratory response, followed by the other human strains 
except strains S21, S22 and S27 (Figure 5-11). These latter strains and all those from 
animal origin did not demonstrate respiration when this compound was the sole 
nitrogen source. 
5.4.3 L-Ornithine and γ-Amino-N-Butyric acid 
 
Strain S07 has shown the ability to utilise both ornithine and γ-Amino-N-
Butyric acid (GABA) (Figure 5-12 and Figure 5-13). The use of ornithine as a sole 
nitrogen source during growth is dependent on the presence of the enzyme ornithine 
decarboxylase (ODC) (Shaibe et al., 1985b).  
5.4.4 D-Mannosamine 
The majority of human strains except S04, S15, S21 and S22, were able to use 
D-Mannosamine as a sole nitrogen source. The remaining human strains and the 
animal strains showed a much extended lag phase, with this compound and low levels 
of respiration in comparison with the other group (Figure 5-14).  
 
98 
 
 
 
S07 
S07 
Figure 5-12 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period in the presence of the sole nitrogen source     
L-Ornithine 
Figure 5-13 Reduction of tetrazolium violet dye by the 32 test strains incubated at 
37°C over a 26 hr period in the presence of the sole nitrogen source  g-
Amino-N-Butyric Acid 
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D04 
Human 
strains 
except 
S04, S15 
S21, S22 
Animal 
strains 
plus 
S04, S15 
S21, S22 
  
Figure 5-14 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period in the presence of the sole phosphate 
source D-Mannosamine 
Figure 5-15 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period in the presence of the sole nitrogen 
source 6-Phospho-Gluconic acid 
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5.5 Phosphorus source plate PM4a 
 
Plate PM4a contains 59 single phosphorus sources and uses succinate as a carbon 
source. The sequenced DT104 strain uses 34 of these compounds (AbuOun et al., 
2009).  As with the nitrogen plate the most noticeable difference was the lack of 
utilisation by strains S21 and S22. They were only able to respire on two compounds, 
thiophosphate and dithiophosphate. Together with the results from the nitrogen plate 
this again suggests a fundamental problem with either uptake or downstream 
metabolism. The other strains range between 11 and 47 in the number of compounds 
they can use as a sole phosphorus source, with strain S04 using the most. 
5.5.1 6-Phospho-Gluconic acid 
 
Figure 5-15 shows the ability of animal strain D04 to use the compound 6-
phosphogluconic acid as a sole phosphate source. 6-phosphogluconic acid has been 
shown not to be a sole carbon or nitrogen source for S. Typhimurium LT2 (Gutnick et 
al., 1969). The oxidative decarboxylation of 6-phosphogluconate to ribulose 5-
phosphate by phosphogluconate dehydrogenase is part of the oxidative phase of the 
pentose phosphate pathway and results in the generation of NADPH from NADP+. 
This pathway allows the oxidation of glucose for the generation of NADPH, which is 
required for the synthesis of fatty acids, cholesterol and nucleotide biosynthesis. 
In S. Typhimurium LT2 the level of phosphogluconate dehydrogenase did not 
vary during variable growth conditions (Winkler et al., 1978), whereas in E. coli the 
level of 6-phosphogluconate dehydrogenase has been shown to be directionally 
proportionate to cellular growth rate during growth in minimal media (Jones et al., 
1990). 
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5.6 Sulphur source plate PM4a 
 
Plate 4a also contains 36 sole sulphur sources using succinate as the carbon source. 
The sequenced DT104 was able to utilise 10 of these compounds. Three animal 
strains A01, D03 and D06 showed the inability to use any of these compounds as sole 
sulphur sources.  The rest of the strains used between 9 and 19 of these compounds. 
 A group of four strains showed a tendency for a shorter lag phase when 
utilising these compounds (S04, S07, S27 and D10). Figure 5-16 shows an example of 
this with the compound dithiophosphate acting as the sulphur source.   
 
 
Figure 5-16 Reduction of tetrazolium violet dye by the 32 test strains incubated 
at 37°C over a 26 hr period in the presence of the sole phosphate 
source 6-Phospho-Gluconic acid 
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Discussion 
 
The phenotypic microarray was carried out to help confirm the genetic variations that 
were revealed by the CGH and the optical mapping studies. The microarray results 
have confirmed some of the previous studies’ results, disagreed with others and have 
also posed further questions and possibilities with regards to factors that may affect 
epidemicity. 
 
The presence of the genes involved in allantoin and glyoxylate utilisation were 
reported in strain S15, A01, A02 and D06 by the CGH microarray. The phenotyping 
results support this observation for strains S15, A02 and D06 which showed the 
ability to utilise glyoxylate as a sole carbon source as well as m-tartaric acid which is 
also part of the glyoxylate metabolic pathway. This ability was confirmed and 
definitively linked to growth with S15 via a growth study. The ability to use these 
compounds, which is hypothesised to have become lost before DT104 obtained 
antibiotic resistance, is likely to have an effect on the fitness of the strains in the wild.  
 
 The absence of the ribose operon from one strain, S27, was also investigated 
with the phenotypic array. In this case the genotype could not be associated with a 
corresponding phenotype as all strains show the ability to use the compound (graph 
not shown). Mutations in this region have been shown to disrupt the transport system 
encoded but do not necessarily lead to no growth with D-Ribose as a sole carbon 
source, suggesting an additional transport mechanism for the compound. An 
intermediate in the L-Fucose degradation pathway, L-Fuculose-1-phosphate, has been 
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shown to stimulate the utilisation of D-Ribose via the ribose operon (Autieri et al., 
2007) 
 One marked example of where the genetic information from the optical 
mapping may be linked to an extreme phenotype is with strain S21. As stated the 
40kb insert identified between the genes ppk and guaB, may affect the production of a 
polyphosphate kinase. Ppk mutants have been shown to have reduced survival and 
sensitivity to weak organic acids. Strains S21 and S22, both from the same clinical 
outbreak, (the latter of which was not submitted for optical mapping) show 
dysfunction in the use of the large majority of sole nitrogen and sulphur sources. It is 
possible that the novel insertion has impacted to reduce their fitness in limiting 
conditions or has deactivated some vital process in nitrogen and phosphorus 
metabolism.  
The other variation in the metabolism of sole compounds cannot be directly 
linked to specific gene differences observed from the CGH study. For example the 
absence of the pdu/cob genes from strain D10 was not mirrored by an alteration of 
this strains respiration response on 1,2 propanediol. Another example was the 
utilisation of the sole nitrogen source ornithine by strain S07. As has been stated the 
use of ornithine as a sole nitrogen source during growth is dependent on the presence 
of the enzyme ornithine decarboxylase (ODC). In S. Typhimurium two ODC genes, 
are present speC (STY3270) and speF (STY0739) - but only as pseudogenes, and S. 
Typhimurium has been shown to be unable to use ornithine as a sole nitrogen source 
(Gutnick et al., 1969).  
 
 An interesting observation from the phenotypic results was the divergence in 
utilisation between animal and human strains in the use of N-Acetyl-D-Glucosamine 
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as a carbon source as well as the majority of human strains in the use of D-
Mannosamine as a nitrogen source. The main difference noted from the CGH between 
the human and animal groups was variations in the presence of genes related to 
phages. 
 
Overall some aspects of the phenotyping can be linked to genetic differences 
from the CGH, however the majority cannot. In those cases where genes are present 
but the phenotype is absent, the implication must be that genes are inactive, possibly 
through mutation or their regulatory machinery. The inactivation of some genes, 
perhaps by cold stress, may be responsible for those instances when individual strains 
show different utilisation profiles from the majority of the test strains. 
 
5.7 Persistence within macrophages  
Introduction 
The previous sections have focused on attempts to define the genetic and 
biochemical differences and similarities between the strains covering the time span of 
the DT104 epidemic. The data suggest a degree of clonality within DT104 strains and 
that the major variability is related to SGI1 and certain prophages as well as with 
some strains the region related to allantoin and glyoxylate utilisation. The Biolog data 
however suggests there were more subtle variations and phenotypic variability than 
might be anticipated on the assumption that the CGH data will correlate directly with 
the phenotype. Whilst that correlation is true the majority of genes, no doubt there 
were some discrepancies suggesting variability within genes, such as point mutations 
or alternative regulatory mechanisms, resulting in phenotypic differences.  
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A key part of the thinking around the emergence of an epidemic is the 
possibility that the bacterial strains themselves, through adaptation, become more 
competitive in the ‘wild’ and cause the rise of an epidemic. Similarly the decline of an 
epidemic may be the result of loss of fitness of the bacterial strains. Thus, given the 
differences that have been described in the panel of strains by the preceding 
descriptive genotypic and phenotypic tests that have been performed thus far in the 
study, it seemed sensible to test a facet of the biology of the strains that relates more 
to the relationship with the host. The induction of the glyoxylate cycle has been 
shown to be induced inside macrophages and so a study into the persistence of a panel 
of strains inside macrophages was carried out. 
5.7.1 U937 human macrophage results 
 
The survival and even proliferation of bacteria in the intracellular spaces of the host, 
be they in the epithelial cells of the gut or within macrophages, will have an important 
impact on the outcome of a Salmonella infection. U937 human macrophage and RAW 
264.7 murine macrophage cells were chosen for the assay, and the protocols derived 
from (McNally, 2006) and (McNally, 2007) were followed. Representative strains 
were chosen with varying resistance profiles. Persistence was measured as cfu/ml 
after incubation with gentamicin after either 5 or 24 hours.  
Figure 5-15 shows the data obtained from the seven strains at the three time 
points (2 hour, 5 hour and 24 hours). At the control point the DT104 strains show 
comparable numbers, with the sequenced DT104 strain being around half a log. 
higher. Each of the DT104 strains shows around a 1 log drop in numbers from the 
control point until the 5 hour persistence point, with S27 having a slightly larger drop. 
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The main difference between the DT104 strains is shown at the 24 hour persistence 
time point. Here the sequenced DT104 strain showed a large decrease of almost 2 
logs, while the strains S06, S27 and A02 showed about a 1 log drop-off, and  strains 
S15 and S16 showed a very small decrease indicating a higher level of persistence. 
A variance analysis was carried out to assess the significance of the data. 
These included a comparison between all strains at all time points and between just 
the DT104 strains at all time points. The data for the DT104 strains is shown in Table 
5-3. The null hypothesis that there is no significant difference in the variance between 
the strains at each of the time points is rejected with a confidence over 99.5%. 
 
Figure 5-15 Persistence in U937 macrophages. Data obtained from seven of the strains at the 
three time points; 2 hours (control, represent adhesion and invasion) and 5 and 
24 hours (representing persistence). Each point shows the average of the 
replicates.  
 
Graph plotted on a logarithmic scale. Error bar represent the standard error (standard 
deviation divided by the square route of the number of samples.   
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Table 5-3 ANNOVA values for DT104 strains at the three time points. All F values exceed 
the F-critical value for P values <0.05. Thus variance between strains is 
statistically significant. 
 
 F P-value F crit 
Control (2hrs) 4.330 0.001 2.272 
5hrs 2.490 0.034 2.272 
24hrs 3.091 0.011 2.272 
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6 Discussion 
Non-typhoidal Salmonella infections are a major public health concern. There are 
over 2500 serovars of Salmonella but a relative few of them cause the majority of 
human infections (Anjum et al., 2005). When an epidemic strain emerges it can 
spread across a wide geographic region before it then subsides. This pattern has been 
seen with successive epidemics for example with S. Enteritidis PT4 (Velge et al., 
2005) and multidrug resistant S. Typhimurium DT104. MDR DT104 which was first 
isolated in the UK in the 1980’s, was later found to have spread to Canada, France, 
Germany and the United States. First found in cattle, DT104 was later isolated from 
poultry, pigs and sheep as well as from human infections. As has been mentioned 
earlier in this thesis, it is recognised that an epidemic occurs through a combination of 
factors that can be simplistically considered as the interaction between the pathogen, 
the host and the environment. The genetic mechanisms underlying this epidemic and 
their possible implications for the fitness of the strains were the target of this study.  
The hypothesis for this study was that DT104 emerged due to genetic changes 
that contributed to enhanced fitness. To test this proposition isolates from before, 
during and after the epidemic were studied, to discern those genetic changes 
associated with the epidemic. This assumes that genetic differences play a key role in 
the overall process and that these may be distinct from genetic drift say through the 
accumulation of single-nucleotide polymorphisms (SNPs). The evidence for this 
hypothesis is the fact that before and after the epidemic, fully sensitive strains of 
DT104 were commonly isolated whereas during the epidemic, MDR isolates were 
most often recovered. DT104 had indeed acquired a significant number of genes that 
were not just antibiotic resistance genes but were part of an associated element with 
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44 ORF’s genes defined as the Salmonella Genomic Island 1. The gaining of 
antibiotic resistance by a clone of DT104 that became epidemic may have triggered 
the epidemic, and the variants and loss of the acquired genes could have reverted the 
strains to a ‘less epidemic’ state and thus led to the decline of the epidemic. The 
alternative could be that a clone of DT104 acquired the new genes and has since 
evolved separately. In this case one could argue that for DT104 the fully sensitive 
clone is ‘less epidemic’ than the MDR derivative. After the epidemic the less 
epidemic clone may still persist. For either of these scenarios it is assumed that the 
environmental and host contributions are broadly the same.  
The strains for this study were chosen based on the criteria of date of isolation, 
host species and resistance profile. The S. Typhimurium serovar is commonly isolated 
from cattle but has also been found in other species. Therefore a comparison between 
strains isolated from animal and human sources enabled the consideration of genomic 
host specificity as well as epidemicity. In addition a range of antibiotic resistances 
have been reported in DT104, therefore variant profiles were chosen to allow 
consideration of the evolution of antibiotic resistance within the phage type, and its 
possible implications for the ‘epidemicity’ of DT104. Epidemicity is defined as ‘the 
quality of being widely diffused and rapidly spreading throughout a population’, 
(Saunders Comprehensive Veterinary Dictionary, 3 ed). Here the term is used in the 
context of increased isolations from a wider source of hosts. For DT104 it seems 
likely the primary source was bovine in nature (Threlfall, 1994), and other species 
first contracted it through food borne transmission or direct contact. 
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While considering the genetic underpinning of epidemicity within DT104 we 
should first consider if the CGH approach is justified. Preliminarily we should 
consider whether there are differences to consider at a genetic level beyond that of the 
known SGI1. The general clonality of the DT104 phage type has been reported on, 
however the presence of variant clones has also been observed (Liebana et al., 2002). 
Lan et al. (Lan et al., 2009) have looked into the population structure, origins and 
evolution of major Salmonella enterica clones using publically available MLST data. 
From the available S. Typhimurium MLST data they saw that the 46 isolates they 
studied were grouped into 12 strain types. Of these 9 belong to a clonal complex with 
ST19 as a founder, differing by between 1-5 base changes. A total of 93% of isolates 
reside within the ST19 complex. The remaining ST’s are hypothesised as having 
independent origins, and these include ST36.  
Within the S. Typhimurium serotype, DT104 is not genetically homogenous 
and was associated with 4 ST types (ST19, ST40, ST153 and ST209). Of these only 
ST40 lays outside the ST19 clonal complex. MLST data from the current study shows 
that 75% of the DT104 strains (26/30) reside within the ST19 complex, whilst only 4 
strains; S15, A01, A02 and D02 were not designated as ST19.   
These results may indicate that these outlier DT104s have either diverged 
from the main grouping of DT104, or that DT104 may have developed from one of 
these variant strains and that that strain may be considered an ancestral type. The 
mobility of phages could also suggest that two evolutionarily unrelated strains could 
have been infected with the same pattern of phages, which independently produced 
the DT104 type.  
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The typing techniques used also demonstrated their limitations, in the ability 
to detect further variation within the closely related DT104 strains. This justified the 
choice of comparative genomics to interrogate the underlying reasons for the 
development of epidemicity, by considering specific gene variation.  
When studying genetic differences within DT104 to identify what 
characterises epidemic strains, it is then important to consider three factors; antibiotic 
resistance, fitness and virulence. These concepts will colour the interpretation of the 
data. The factors are interlinked and can be inter-dependent, and can therefore form a 
complex picture and have a profound impact on epidemicity 
6.1 Antibiotic resistance 
 
Antibiotic resistance is the first of the three strain features discussed here as being 
potentially associated with epidemicity. The emergence of S. Typhimurium DT104 as 
an epidemic strain in cattle in the late 1980’s and early 1990’s seems to have 
coincided with the strains acquiring antibiotic resistance, predominantly the penta 
resistance ACSSuT phenotype. The question must thus be posed, did the acquisition 
of antibiotic resistance by DT104 lead to it becoming an epidemic strain, or did a 
strain with the potential to cause an epidemic then gain antibiotic resistance, and has 
later variation or loss of the region led to the decline of the epidemic. 
 It has been shown that with Typhimurium DT104, resistance is 
chromosomally located on a 43kb genomic island (Boyd et al., 2001). This genomic 
island called SGI1 has been classified in the Salmonella Typhimurium DT104 and 
been shown to contain a 13kb region with genes encoding antibiotic resistance. The 
region is chromosomally located at the 3’ end of the thdF gene, and is flanked by 
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18bp direct repeats. The region consists of a floR gene for chloramphenicol resistance 
and tetR / tet(G) for tetracycline resistance with two class integrons, one containing an 
aadA2 cassette and the other a blaPSE-1 cassette (Briggs, 1999; Lawson, 2004; Mulvey 
et al., 2006). This represents the ‘classical’ genomic island from penta -resistant 
DT104 and confers the ACSSuT type.   
The origin of this island is not known. In discussion with experts in the field 
(Rob Davies, personal communication), there was no evidence of major cattle 
husbandry changes at the time of the emergence of the epidemic as a contributing host 
or environmental factor. That said, the acquisition of the MDR phenotype may have 
given selective advantage in the face of antimicrobial treatments. It has been 
postulated that it emerged in response to the use of antibiotics during intensive calf 
rearing in the 1970’s. The resistances conferred by the island target 4 of the 5 most 
commonly used veterinary antibiotics during this period (aminoglycosides, β-lactams, 
sulphonamides and tetracyclines (Velge et al., 2005)). Whether it was this that caused 
the creation and acquisition of the SGI1 or more subtle changes in antibiotic use 
around the epidemic period is unknown. Some of the genes; aadA2, blaPSE-1 and sul1 
are found amongst the Enterobacteriaceae whilst it has been suggested that the floR 
and tet(G) may come from the fish pathogens Photobacterium damselae and Vibrio 
anguillarum, where the genes have been found (Angulo et al., 2000). Another 
possible source for these later genes is Pseudomonas sp. that can contain. tet(G) 
(Schnabel and Jones, 1999) and a close homolog of floR, cmlA. These issues need 
further investigation but were considered significantly beyond the scope of this thesis. 
Other variants of the genomic island have been reported with different 
resistance profiles, due to rearrangements or additions and / or subtractions to this 
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region (Levings, 2007; Threlfall, 2004). This change in resistance profiles shows the 
plasticity of this genetic system and the speed at which such changes can occur. The 
CGH microarray data has revealed variation within the SGI1 between strains. It has 
identified 4 strains (D02, S21, S22 and S24) as have the variant SGI1-C, although 
sequencing would be needed to confirm this. The strains that are sensitive, from both 
animal and human origin, lack all but three of the genes from this region, including 
those genes with phage/plasmid relatedness and those containing gene cassettes that 
confer the antimicrobial resistance. 
The two genes shown to be present in all the test strains, regardless of 
antimicrobial resistance, were SDT3852 and SDT3862. Both have relatedness as 
determined by blast search to qacEΔ1 and sul1, a gene pair associated with the 3’ 
conserved region of a class 1 integron. Class 1 integrons have been associated with 
antimicrobial resistance in many Gram negative organisms and are characterized by 
the presence of a 5’ conserved segment containing an integrase gene (intI1), a 3’ 
conserved segment containing qacEΔ1 and sul1 genes, and a central attI 
recombination gene (Fluit and Schmitz, 1999). It is likely that positive presence of the 
two genes, even in strains that display no antimicrobial resistance, demonstrates the 
ubiquity of class 1 integrons. Indeed SDT3862 shows significant blast homology to 
part of the S. Typhimurium virulence plasmid pSLT.  
Gene SDT3829 is also shown to be present in all the strains apart from A01, 
A02 and D06. This gene shows blast similarity to a rep gene and also to a mating pair 
stabilization protein gene. The rep gene from E. coli codes for a helicase, a DNA 
dependent ATPase needed by some phages for their replication (Gauss et al., 1994). 
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Therefore it is possible that the positive response to this gene from the majority of the 
sensitive strains may indicate its presence in another phage present in the genome.  
Two of the strains used in this study presented expanded resistance profiles 
when compared to the ‘typical’ penta resistant DT104. Strain S05 demonstrated an 
additional resistance to trimethoprim. S06 showed additional resistances to the 
quinolone, naladixic acid and ciprofloxacin, a second generation fluroquinolone. 
 Quinolone based antibiotics work by targeting DNA gyrase or topoisomerase 
IV and therefore interfering with cell division. Resistance to these antibiotics is 
primarily conferred by mutations in the quinolone resistance-determining regions 
(QRDRs) of genes coding for these targets, gyrA and gyrB for DNA gyrase and parC 
and parE for topoisomerase IV. An additional role in resistance by efflux mechanisms 
associated with the AcrAB efflux pump has been suggested (Giraud et al., 2000). 
These resistance mechanisms are unrelated and distinct from the SGI1 region. This 
kind of mutational change would not be detected by the CGH microarray, and only 
gene sequencing techniques would reveal it. In addition, a secondary attachment for 
SGI1 has been discovered via R1 plasmid mediated transformation with Salmonella 
Typhimurium LT2. This is located in the intergenic region between the chromosomal 
sodB and purR genes (Doublet et al., 2008). This shifting of the island would not be 
detected by the CGH microarray, but could have an effect on the epidemicity of the 
strain if present. 
Additional resistance genes, associated on the array with the S. Typhi plasmid 
HCM1, were identified in some of the resistant strains. These genes, 
bla
TEM, strA, 
strB and sul2, have recently been associated with a clonal group of S. Typhimurium 
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and its monophasic variant Salmonella enteric sbsp. enteric serovar 4,[5],12:i:- that 
emerged during the 2000’s. It has been isolated in Spain, Italy, Luxembourg and the 
US (Soyer et al., 2009). These strains display the resistance profile ASSuT and the 
resistance genes have been shown to occur in a separate and distinct chromosomally 
encoded region when compared to SGI1 (Lucarelli et al., 2010).  This serotype is of 
increasing concern as it seems to be undergoing an epidemic phase. The presence of a 
subset of these HCM1 genes, but not the whole plasmid, suggests that the test strains 
from the current study may contain this newly identified region or another plasmid or 
plasmids with these genes. 
The lack of information on the location of and spatial relationship between 
genes provided by the microarray results means that it is impossible to pin down the 
exact nature of the resistance profiles from this data alone.  The ability of techniques 
such as sequencing and optical mapping to identify variation in SGI1 related regions 
and detect novel insertions demonstrate their ability to monitor the evolving nature of 
chromosomally based antibiotic resistance. 
Overall the acquisition of the ‘classic’ resistance profile did coincide with the 
understood period of epidemicity. The later development of variant SGI1 regions also 
seems to have coincided with the decline of the epidemic, perhaps suggesting that the 
penta resistance profile acquired was the important factor in the prevalence of DT104. 
However some of these variations led, in fact, to resistances to a wider spectrum of 
antimicrobials. This may suggests that resistance in itself was not the only driving 
force of increased fitness and therefore the epidemic. 
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6.2 Fitness 
Genomic differences that could affect fitness and therefore the spread of the strains - 
the second feature potentially related to epidemicity in this discussion - were 
identified by the microarray. Genes for allantoin and glyoxylate utilisation were found 
as being present in three sensitive animal strains, A01, A02, D06 and  one of human 
origin, S15.  Three of these strains – A02, D06 and S15 – showed the ability to utilise 
glyoxylate as a sole carbon source. The loss of this region of genes has been 
hypothesised to have occurred before antibiotic resistance acquisition (Matiasovicova 
et al., 2007), and as such, it is possible that a sensitive DT104 strain containing this 
region could represent an ancestral strain. 
Allantoin is a product of purine degradation as it is transformed into urea and 
glyoxylate via ureidoglycolate. E. coli has been shown to use allantoin as a sole 
nitrogen source, but not a carbon source, under anaerobic conditions (Cusa et al., 
1999). This pathway and the position of the genes within it are shown in Figure 6-1. 
Allantoin is broken down by successive enzymes, producing ammonia and ultimately 
glyoxylate. Glyoxylate can then be utilized in general metabolism. The process of 
allantoin degradation is part of a larger pathway that allows the breakdown of uric 
acid. Higher mammals, including humans, do not express uricase, the enzyme that 
breaks down uric acid to allantoin. It is therefore likely that allantoin will be 
unavailable in these hosts. In other host animals, including poultry, the enzyme is 
present and therefore allantoin may be available (Fujiwara and Noguchi, 1995). 
Allantoin is one of the materials that accumulates inside avian eggs during 
development and as such may provide one of the few nitrogen sources (Fisher and 
Eakin, 1957). The ability to use allantoin as a nitrogen source may be a significant 
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advantage to bacteria in these environments when other sources of nitrogen are 
scarce. The lack of the ability to utilise allantoin as a sole nitrogen source, by these 
strains, as determined in the Biolog study, may be an artefact due to the aerobic 
conditions of the assay. 
Figure 6-1 Allantoin degradation pathway to Glyoxylate. Adapted from (Cusa et al., 1999). 
 
The glyoxylate cycle of central metabolism allows the bypassing of two 
decarboxylation steps of the TCA cycle, moving from isocitrate via glyoxylate to 
malate. It facilitates the use of 2-carbon compounds such as acetate and ethanolamine 
as sole carbon sources (Weissbach, 1953a, b). This process is termed the glyoxylate 
shunt and has been associated with growth in carbon limited environments.  The 
genes present in the STY0566 – STY0577 that are involved in this process are 
identified in Figure 6-2.  
 
The STY0567, glxR gene encodes for tartronic semialdehyde dehydrogenase, 
STY0573, glxK for glycerate kinase, and STY0566, hyi for hydroxypyruvate 
isomerase which interconverts tartronic semialdehyde and hydroxypyruvate 
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(Ashiuchi, 1999).  The 3-phosphoglycerate formed can be fed into glycolysis 
metabolic pathway, and thus to central metabolism. It is suggested that the glycerate 
formed from glyoxylate is oxidised into the TCA cycle via acetyl-CoA in E. coli 
(Ornston and Ornston, 1969). 
Figure 6-2 Glyoxylate degradation pathway to 3-Phosphoglycerate. Adapted from 
(Ornston and Ornston, 1969) 
 
 
 
One of the suggested advantages of the presence of the ability to use the 
glyoxylate shunt of the TCA cycle is intracellular survival when nutrients are limited, 
for example inside macrophages (Lorenz, 2002). With a lack of more usual sources of 
carbon, such as glucose, the TCA cycle, with its two decarboxylation steps is unable 
to work. The glyoxylate pathway bypasses decarboxylation thus allowing 2-carbons 
to be used. The source of these 2-carbon compounds could be the breakdown of fatty 
acids from lipids within host cells (Chung, 1988; Maloy, 1980).  
The presence of the genes involved in the allantoin / glyoxylate pathway 
would be thought to increase the fitness of the strain in some environments, 
specifically those that may be nutrient deficient. Whether the loss of this region may 
have had influence on either epidemicity or DT104 gaining antibiotic resistance is 
unknown. One speculative hypothesis could be that a reduction in the ability to 
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survive within intracellular spaces may have caused the bacteria to become exposed to 
more selective antimicrobial pressure in the extracellular environment.  
  The ability of strains to use other extra compounds compared to the sequenced 
DT104 may also confer a fitness advantage. For example the resistant strain S07 was 
observed to use ornithine as a sole nitrogen source. The speC gene for ornithine 
decarboxylase is found in four members of Enterobacteriaceae; Citrobacter freundii, 
S. Typhimurium, Klebsiella pneumoniae and Enterobacter aerogenes (Wright and 
Boyle, 1984). In S. Typhimurium two ODC genes, speC (STY3270) and speF 
(STY0739) were present but only as pseudogenes and S. Typhimurium has been 
shown to be unable to use ornithine as a sole nitrogen source (Gutnick et al., 1969). 
This is as opposed to the situation in E. coli where ornithine can be used (Shaibe et 
al., 1985a). 
The pathway of ornithine utilisation leads to the formation of γ-amino-N-
butyric acid (GABA). It has been shown that mutations in the gab regulatory locus 
lead to a decrease in the activity of GABA aminotransferase. Strain S07 also showed 
the ability to use GABA as a sole nitrogen source. These phenotypes may confer a 
fitness advantage to this strain. This result, from the phenotyping microarray, again 
demonstrates one of the drawbacks of the CGH microarray. A gene presumed 
‘pseudo’ but actually actively transcribed will not be detected.  
The ribose operon rbsDABCKR codes for a high affinity ABC transporter 
which allows the utilisation of D-ribose as a carbon source. It was identified on the E. 
coli K-12 chromosome at min 84 (Lopilato et al., 1984). The loss of this region in 
sensitive strain S27 is notable. It is possible that its excision is an artefact of lab 
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attenuation, perhaps because of its storage at low temperature. However, as has been 
noted, the region involved in allantoin and glyoxylate utilisation was lost from DT104 
at some point before the epidemic and so perhaps this result demonstrates that even 
the regions outside the ‘mobile elements’ are more fluid then is generally thought. 
As has been noted from the results from the optical mapping method a 40kb 
insert was identified in strain S21, between the genes ppk and guaB. If the ppk, 
polyphosphate kinase, gene has been disrupted there may be implications for the 
fitness of the strain. Mutant ppk derivative strains have been shown to have reduced 
survival and sensitivity to weak organic acids (Brown and Kornberg, 2004; Price-
Carter et al., 2005). As was stated this strain and S22, likely from the same outbreak, 
show the same inability to use the majority of nitrogen and phosphorus compounds. 
Variation in the uptake of peptides by S. Typhimurium with mutations in the peptide 
uptake mechanisms; oligopeptide permease (OPP) dipeptide permease (DPP) and 
tripeptide permease (TPP) have been demonstrated and it is possible that a 
dysfunction could exist in one or all these mechanisms in the two strains (Goodell, 
1987; Hiles, 1986). These strains are resistant human isolates from the post-epidemic 
period. The suggested decrease in their fitness had not prevented them from being 
isolated from human infections, but may be an indication of the process by which an 
epidemic strain begins to decline.  
6.3 Virulence 
 
Virulence is the third key strain feature discussed here as presenting a possible link 
between the genetic properties and epidemicity. Here, variation in a region associated 
with a ‘pertussis like’ toxin was observed in the DT104 strains through the CGH 
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microarray data. Bordetella pertussis produces an ADP-ribosyltransferase toxin that 
causes the ADP-ribosylation of the G proteins and interferes with intracellular 
communication.  This class of toxin consists of two components: an ‘A’ unit coding 
for the toxin including an active site, and a ‘B’ unit required for receptor binding and 
translocation across cell membranes. ADP ribosyltransferases are associated with 
severe human diseases such as diphtheria, cholera and pertussis. 
The genes that code for the toxin, listed as STY1361-STY1367 in the 
Salmonella enterica serovar Typhi CT18 genome, have been reported as inactive in 
DT104 because of at least one frame shift (Hermans, 2005a; Parkhill, 2001). However 
a recent study has shown that the genes in this region can be transcribed in DT104 and 
produce an ADP ribosyltransferase that can affect Chinese hamster ovary cells in a 
similar way to an E. coli shiga toxin (Uchida, 2009). A study using the selective 
capture of the cDNA transcribed sequences from macrophages containing Salmonella 
Typhi has reported that the genes STY1361-STY1367 are upregulated, which 
suggests that they play or may have played a role in bacterial virulence or survival 
within phagocytes (Faucher, 2005). 
The pattern of presence of these genes in the DT104 strains is interesting. The 
human strains from the epidemic period, excepting S15, showed the presence of the 
genes, most of the animal strains and the early sensitive human strains showed the 
presence of some of the genes while five strains A01, A02, D02, D03 and S15 showed 
the complete absence of the region. The study into this region was extended, with 
confirmatory PCR and the sequencing of the ‘toxin’ genes. The absence of the region 
from the five strains was confirmed and variation in the region was seen amongst the 
other strains from the sequencing results, although it did not marry directly with the 
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CGH microarray data. If, through further study, they can be shown to be active in the 
strains from the epidemic period but not those from the pre-epidemic, it could have 
fundamental implications in understanding the mechanisms behind the epidemic. To 
draw such a conclusion much more extended investigation is required. 
One of the overarching conclusions from the genetic data is that most 
differences can be connected to mobile genetic elements. These can be bacteriophage 
related, have plasmid origin, can represent genomic islands that can be shown to be 
mobilizable or are pathogenicity islands whose G+C content divergence from the 
general genome indicates their ‘foreign’ origin (for example SPI2 has G+C content of 
43% compared to the rest of the Salmonella genome  at 52% (Hensel, 2004)). The 
transfer and integration of these mobile elements allow Salmonella to take so called 
‘quantum leaps’ in bacterial evolution (Groisman and Ochman, 1993). 
The acquisition of pathogenicity islands is one of the main means by which 
Salmonella has obtained virulence determinants. Salmonella pathogenicity island 1, 
SPI-1, is present in S. bongori and all serotypes of S. enterica tested thus far (Ochman 
and Groisman, 1996).  Sensitive strain S13 lacks three genes from this region; 
STY3006 sipD, STY3007 sipC and STY3014 spaO. SipC is a cell invasion protein 
associated with the needle-like apparatus that is expressed inside murine and porcine 
macrophages. SpaO, is one gene from the inv-spa invasion gene complex, coding for 
a component of the TTSS of SPI-1. SPI-1 is responsible for aspects of the invasion of 
non-phagocytic cells via the rearrangement of the host actin cytoskeleton and is also 
implicated in the inflammation of the intestinal epithelium (Hensel, 2004). 
Dysfunction in this area would likely have a negative impact of the pathogenicity and 
virulence of the bacterium.  
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The animal resistant strains D05, D10-D12 were shown to have a few 
additional genes from the identified SPI-7 region (Pickard et al., 2003). With D10 this 
includes the genes STY4617 and STY4622, two genes that bookend the genes lysB, 
nucD and nucE in SPI-7. The SPI-7 in S. Typhi contains the genes for the Vi antigen 
that is expressed as a capsular exopolysaccharide. The region also contained the sopE 
phage, which produces the effector protein SopE. The S. Gallinarum genome contains 
a degenerate SPI-6, that is present in sensitive strains A02 and S15, whilst the S. 
Typhi SPI-6 region is missing in the same strains. The deletion of SPI-6 from S. 
Typhimurium had no effect on systemic pathogenesis but does seem to lead to the 
reduced invasion of cultured cells (Folkesson et al., 2002). 
Infection by bacteriophages may also provide a route for the acquisition of 
virulence determinants. As was observed the human strains, except S19 and S30, 
showed the presence of genes from the Fels-1 phage. A study by Hermans et al 
(Hermans, 2005b) on 18 S. Typhimurium DT104 strains did not detect the presence of 
the Fels-1 phage by genomic subtractive hybridisation. Some genes of Fels-1 have 
been shown to cross hybridise with open reading frames of prophage homologs in 
LT2 (Andrews-Polymenis et al., 2004). The presence of Fels-1 genes in some DT104 
strains could have implications for virulence. Fels-1 contains sodCIII, a superoxide 
dismutase and nanH, a neuraminidase. Superoxide dismutase provides bacteria which 
some protection from the oxidative burst in the intracellular environment and is linked 
to bacterial survival. The role of neuramidase in virulence has not been elucidated, 
although a role for it in bacterial biofilm production during mucosal infection has 
been reported (Soong et al., 2006). The presence of these genes in the human DT104 
strains could be indicative of the presence of this or a related phage. 
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Two animal resistant strains where shown to lack the Gifsy-1 phage. Gifsy-1 
contains a gogB gene which produces a type III secreted substrate. This protein is 
secreted by the TTSS of the pathogenicity islands SPI-1 and SPI-2, and is translocated 
into the host cells in a SPI-2 mediated process, via the ssrAB system (Coombes et al., 
2005). The gogA gene is also present in Gifsy-1, and shows homology to pipA from 
the SPI-5 of S. Dublin. Gifsy-1 also contains ehly-1 which in enteropathogenic E. coli 
produces an enterohemolysin. 
The presence of these mobile elements and the variation that has been shown 
within the DT104 strains demonstrates how strains obtain different combinations of 
virulence determinants. It also shows how a strain may suddenly develop 
characteristics that may both positively and negatively affect its epidemicity.  
 
6.4 Conclusion 
 
When considering epidemicity it is important to understand the factors that underlie 
the spread of a strain and its virulence. If a strain is too virulent it will so adversely 
affect its host that it limits its own spread, similarly if the acquisition of virulence 
determinants has a serious deleterious effect on a strain’s fitness it again will not 
become epidemic. A highly fit and virulent strain with no antibiotic resistances would 
again be sorely hampered in becoming epidemic, being adversely affected by both 
man-made and naturally occurring antimicrobials. However the acquisition of 
antibiotic resistance may have same genetic cost on the fitness of a strain as the 
acquisition of virulence determinants. 
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So the barriers to epidemicity are significant, and yet wave after wave of 
epidemics are reported. Bacteria have developed two important strategies to enable 
them to overcome these obstacles. First, and not to be overlooked, is the growth rate 
of bacteria and the advantage this gives from an evolutionary standpoint. E. coli has a 
textbook doubling time of 20mins under ideal conditions, although this is no doubt 
extended in the wild. With the growth curves performed for this study, DT104 entered 
the exponential growth phase in LB-broth after 2 hours. This ability to proliferate 
rapidly means that, with the natural mutational frequency for bacteria between 10
-7 
and 10
-11
 per base pair per single round of replication (Madigan et al., 2006), 
mutations are quickly accumulated within the population. Many are of course 
reversed by cellular DNA repair mechanisms, or are deleterious and therefore 
evolutionary dead-ends. However the chance of a beneficial mutation becoming fixed 
is high enough to drive evolution in response to selective pressures. Indeed 
microbiologists take advantage of this process when they select for antibiotic 
resistance in laboratory strains. For example repeated growth of Salmonella strains on 
nalidixic acid gradient plates can select for stains that have developed resistance to the 
antibiotic, and it has been shown that this occurs because of spontaneous mutations in 
the gyrB gene (Yoshida et al., 1991). 
The second process that bacteria use to facilitate their evolution and that can 
play a critical role in their epidemicity is horizontal gene transfer. As has been 
reported in this study the majority of genetic variation involves mobile or mobilizable 
genetic elements. This is the route by which Salmonella has gained both virulence 
determinants, in the form of pathogenicity islands, and antibiotic resistance, in the 
form of plasmids in S. Typhi and as genomic islands with DT104. In addition 
transduction or lysogenic conversion with bacteriophages containing virulence genes 
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can lead to these being integrated in the bacterial genome. The process of horizontal 
gene transfer allows bacteria to make evolutionary jumps, and may explain why a 
strain suddenly gains a set of genes that trigger its journey to becoming an epidemic 
strain. 
The evolution of antibiotic resistance may in fact go hand in hand with that of 
virulence. One theory of the source of resistance genes is that they originate from 
organisms that produce antibiotics themselves, and act as a defence against their own 
products (Davies, 1997; Webb and Davies, 1994). Other resistances may have 
developed from genes with a different functional role within the genome. For example 
the AcrAB-TolC multidrug efflux system in DT104 mediates additional quinolone 
resistance (Baucheron et al., 2004). It has also been demonstrated that E. coli and S. 
Typhimurium extrude bile salts through the acrAB system, a prerequisite for the 
colonisation of the intestinal tract (Ma et al., 1995). S. Typhimurium mutants with a 
high susceptibility to bile salts were shown to have mutation in the acrB gene of the 
MDR efflux pump, and decreased ability to colonise the murine intestinal tract 
(Lacroix et al., 1996). This example shows that antibiotic resistance and virulence 
may develop together, and become co-selected. 
In the case of the CGH microarray results for the DT014 strains it is difficult 
to pin down the precise reasons for the rise of the epidemic during the 1980’s and 
1990’s. Part of this difficulty is due to the complexity of the interaction between 
antibiotic resistance, fitness and virulence and part is due to the drawbacks of the 
technique itself. It could be hypothesised that the presence of the SGI1 itself was the 
driving force behind DT104’s rise, but this in itself would not necessarily lead to an 
increase in virulence and the clinical symptoms that would lead to its isolation. There 
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is a tantalising proposition that the presence of an ADP-ribosyltransferase in the 
epidemic human strains could have an effect, but this would have to be investigated 
much more intensely. The loss of the region involved in allantoin and glyoxylate 
metabolism may have changed the strain’s preferred environmental niche to one that 
led it to become more virulent. Loss of metabolic genes has been linked to virulence, 
in Shigella the loss of the cadA for cadaverine sysnthesis increases its virulence, as 
that enzyme has been shown to inhibit the Shigella enterotoxin (Maurelli et al., 1998).  
Overall the CGH microarray has identified variation between DT104 strains 
from the epidemic and non-epidemic periods. The assumption behind that analysis is 
that the CGH method generated data is ‘accurate’ and this should be treated with a 
degree of caution. On the most basic level the technique interpretation depends on the 
annotated sequences from a few control strains. Genes identified as present may in 
fact be pseudo, orthologs or paralogs and the reverse is also true - genes identified in 
the annotation as ‘inactive’ may be able to be transcribed in the test strain. Strain S07 
and the speC genes for the use of ornithine may be an example of this. The variation 
with phage genes, which by their nature may have a high degree of degeneracy and 
mosaicism, is hard to draw definitive conclusions on.  
The statistical processing of the CGH microarray data through the Genespring 
software using Lowess normalisation as well as the decisions taken on the use of the 
ln(Cy5/Cy3) ratio for the precise cut-off for present/absent genes, were made to 
minimise the possibilities of false positives.  However one of the weaknesses of the 
CGH method is still its statistical robustness, and therefore an attempt should always 
be made to confirm observed differences. Since the location of ‘spots’ on the 
microarray is randomised, differences in sequential runs of genes, i.e. from the same 
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operon, as with the allantoin / glyoxylate utilisation region, can be considered sound, 
especially when supported by phenotypic data. Other gene differences such as with 
the SGI1 were confirmed with the MIC and the optical mapping. The ‘pertussis toxin 
regions’ presence and absence, because of its possible impact, was confirmed by PCR 
and further investigated by sequencing. The observation of other variation can be 
anecdotally confirmed by other studies, i.e. with variation in the pdu/cob region 
(Anjum et al., 2005). .  
Given that the results from this study did show genetic differences with 
correlated and uncorrelated phenotypes for the test strains, it is now important to 
revisit the testable hypothesis and assess whether the changes were associated with 
epidemicity. This study has shown that non-epidemic early strains lack the SGI1 
region and that the presence of this region is one of the defining characteristics of 
epidemic strains. The later variation of this region also corresponded with the time 
when the epidemic was in decline. The early non-epidemic strains along with strains 
with an animal origin show variation in a toxin associated region, whereas the 
epidemic strains have the complete region. Other DT104 strains with different ST 
types show the presence of genes involved in allantoin and glyoxylate metabolism, 
whose loss may have preceded the epidemic.  
At first sight the major genetic differences uncovered by this study would be 
thought to have a detrimental effect on fitness and then by association on epidemicity. 
The insertion of a large genomic island into the genome, a dysfunction in allantoin 
and glyoxylate metabolism and even the possible production of a toxin all carry a cost 
for the bacteria and could be thought to reduce its fitness. However DT104 became an 
epidemic strain. In addition there were numerous other differences observed and it is 
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difficult to tease out whether these were ‘noise’ associated with ongoing evolution of 
the epidemic type or part of the genetic selection that was associated with 
‘epidemicity’. This study had underlined the complexity of underlying bacterial 
epidemics but has also uncovered interesting avenues for further investigation which 
may lead to a better understanding of epidemicity. 
6.5 Future work  
 
There are many possibilities for future work given the plethora of data produced by 
the CGH microarray and the novel techniques used in this study. If this investigator 
were to continue, an examination of the importance and possible implications of the 
region coding for the ‘pertussis like’ toxin would have been the chosen direction. If 
the finding that it can produce an active toxin could be confirmed (Uchida, 2009), this 
could have serious repercussions for the understanding of the DT104 epidemic.  
 
Such work would be carried out by the induction of the toxin from a panel of 
strains, with mitomycin C and hydrogen peroxide, followed by a RT-PCR study to 
detect the transcribed RNA. Further studies could then be done to identify if the toxin 
or its effect is detectable in vitro tissue culture and ultimately in an in vivo murine 
model. 
 
The advances in both the cost and speed of whole genome sequencing mean 
that the usefulness of CGH microarrays is gradually waning. However it can still 
identify strains of interest, and therefore suggest candidates for more in-depth study. 
A number of strains from this study would be possible candidates for full sequencing. 
In addition the optical mapping technique used in conjunction with the CGH has 
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identified a novel insertion in one of the strains, that may have a deleterious effect on 
its phenotype, and this would be another target for sequencing. Another direction 
future work could take is to attempt to close the gap between the genetic and 
phenotypic data. This could be first done by repeating the Biolog assay under 
anaerobic conditions and then by the use of expression microarrays. 
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